Asthma mixed form (mode), excluding more controls

ASTHMA_MIXED_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %J458 Registry filters: Hospital discharge: ICD-10 — J45.8 Cause of death: ICD-10 — J45.8 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: J10_ASTHMA, ALLERG_ASTHMA, VOCALCORDDYS, I9_HEARTFAIL, J10_HYPERSPNEUMONI, ASTHMA_EXCL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_MIXED_EXMORE
CONTROL_EXCLUDE	J10_ASTHMA\|ALLERG_ASTHMA\|VOCALCORDDYS\|I9_HEARTFAIL\|J10_HYPERSPNEUMONI\|ASTHMA_EXCL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%J458
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%J458
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Asthma mixed form (mode), excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Asthma mixed form (mode)

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	25457	12665	12623
Only index persons	21583	11039	10544
Unadjusted period prevalence (%)
Whole population	0.36	0.36	0.35
Only index persons	0.40	0.41	0.40
Median age at first event (years)
Whole population	40.31	48.39	31.78
Only index persons	36.53	46.30	26.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2415	1434	981
Unadjusted period prevalence (%)	0.49	0.51	0.45
Median age at first event (years)	54.26	49.71	60.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2478: Matched controls
24771

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

21.2

320.2

246

128

I50.0

ICD-10 Finland

Congestive heart failure

70.9

307.7

184

XG410

NOMESCO Finland

Flow-volume spirometry

39.9

307.7

212

R03AC02

ATC

salbutamol; inhalant

31.6

307.7

2285

6747

R03BA01

ATC

beclometasone; inhalant

16.6

307.7

910

839

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

130.5

307.7

247

R03AC03

ATC

terbutaline; inhalant

10.9

307.7

741

931

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

213.6

307.7

284

J45.0

ICD-10 Finland

Predominantly allergic asthma

105.6

307.7

727

R03AC13

ATC

formoterol; inhalant

33.8

307.7

340

116

J45.1

ICD-10 Finland

Nonallergic asthma

128.5

307.7

478

XG474

NOMESCO Finland

Exhalation nntrogen oxide

92.0

307.7

271

R03BA02

ATC

budesonide; inhalant

14.7

307.7

1052

1180

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

156.2

307.7

1974

606

R03BB04

ATC

tiotropium bromide; inhalant

57.9

307.7

705

169

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

122.7

307.7

203

J18.9

ICD-10 Finland

Pneumonia, unspecified

18.0

307.7

797

635

R03BA05

ATC

fluticasone; inhalant

15.9

307.7

1139

1256

J46

ICD-10 Finland

Status asthmaticus

160.0

307.7

219

R03AK06

ATC

salmeterol and fluticasone; inhalant

28.8

307.7

1077

645

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

54.1

307.7

513

119

R96

ICPC

Asthma

23.6

307.7

684

394

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

24.0

307.7

310

147

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

68.4

307.7

571

108

J45.8

ICD-10 Finland

Mixed asthma

+∞

307.7

2478

R03AK08

ATC

formoterol and beclometasone; inhalant

45.6

307.7

312

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

50.0

307.7

280

R03DA04

ATC

theophylline; systemic, rectal

33.1

307.7

421

152

R03DC03

ATC

montelukast; oral

20.8

307.7

1117

941

J45.9

ICD-10 Finland

Asthma, unspecified

71.9

307.7

1478

499

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

6.3

307.7

688

1424

UGC12

NOMESCO Finland

Flexible bronchoscopy

30.6

307.7

321

120

I50.9

ICD-10 Finland

Heart failure, unspecified

23.0

307.7

328

163

J45

ICD-10 Finland

Asthma

20.9

307.7

630

398

R03AC12

ATC

salmeterol; inhalant

89.2

307.7

423

H02AB06

ATC

prednisolone; systemic

11.0

307.7

1864

5340

R03AK07

ATC

formoterol and budesonide; inhalant

9.5

307.7

1032

1736

R03BA08

ATC

ciclesonide; inhalant

12.1

307.7

433

425

R06.0

ICD-10 Finland

Dyspnoea

5.1

307.6

866

2340

R03AK03

ATC

[U] fenoterol and ipratropium bromide

16.7

290.7

251

166

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

42.4

281.8

170

R03BB01

ATC

ipratropium bromide; inhalant

20.0

274.5

216

118

XG405

NOMESCO Finland

Education on PEF monitoring

89.8

258.9

136

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

9.0

240.8

316

394

R06.2

ICD-10 Finland

Wheezing

13.6

239.8

232

187

H02AB04

ATC

methylprednisolone; systemic

5.6

229.7

510

1102

J01MA14

ATC

moxifloxacin; systemic

8.8

226.9

305

391

R01AD08

ATC

fluticasone; nasal

4.0

226.1

898

3059

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

7.5

222.0

344

520

R03DC01

ATC

zafirlukast; oral

55.2

213.1

121

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

9.0

195.9

255

313

XQ800

NOMESCO Finland

Prick test

7.4

195.2

302

454

J33.0

ICD-10 Finland

Polyp of nasal cavity

56.4

191.0

108

R01AD01

ATC

beclometasone; nasal

4.5

187.0

545

1460

R03AK11

ATC

formoterol and fluticasone; inhalant

22.8

184.8

136

R06AE07

ATC

cetirizine; oral

3.3

183.7

1316

6352

J01FA06

ATC

roxithromycin; oral

3.3

183.4

1139

5052

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

238.0

173.7

177

R95

ICPC

Chron obstructive pulmonary disease

27.1

173.1

119

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

85.8

172.1

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

453.0

171.9

170

J01AA02

ATC

doxycycline; systemic

4.0

169.2

2028

13059

J34.2

ICD-10 Finland

Deviated nasal septum

40.9

168.0

102

SPAT1059

SPAT

Spirometry at the office

8.5

167.9

227

291

R02

ICPC

Shortness of breath/dyspnoea

4.8

164.0

423

1023

R01AD09

ATC

mometasone; nasal

3.0

156.6

1226

6073

Z01.8

ICD-10 Finland

Other specified special examinations

3.4

154.6

733

2715

C03CA01

ATC

furosemide; systemic

3.4

152.4

735

2748

TGC00

NOMESCO Finland

Bronchial lavation

45.6

148.9

J31.0

ICD-10 Finland

Chronic rhinitis

7.6

147.7

220

315

H02AB07

ATC

prednisone; oral

4.4

147.6

425

1116

R03BC03

ATC

nedocromil; inhalant

6.1

147.0

273

492

EMB10

NOMESCO Finland

Tonsillectomy

29.0

141.7

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

141.0

134

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

17.3

139.7

116

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.3

134.0

666

2513

J35.0

ICD-10 Finland

Chronic tonsillitis

29.7

133.8

49300

ICD-8 Finland

Asthma, bronchiale

+∞

133.5

127

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

347.7

132.9

133

R03BC01

ATC

cromoglicic acid; inhalant

20.0

131.7

102

RD211, ,

NOMESCO Finland

6.5

131.2

226

377

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.7

128.6

1357

7624

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.7

118.7

303

719

J30.3

ICD-10 Finland

Other allergic rhinitis

10.7

118.6

131

128

R06AX27

ATC

desloratadine; oral

2.8

117.5

826

3744

J01FA10

ATC

azithromycin; systemic

2.6

116.6

1511

9226

UDH02

NOMESCO Finland

Rhinopharyngoscopy

8.3

114.4

155

198

WZC30

NOMESCO Finland

Teaching

3.3

113.0

511

1804

R01AD05

ATC

budesonide; nasal

5.3

111.5

240

493

R01AD12

ATC

fluticasone furoate; nasal

2.7

110.9

827

3845

R01AD58

ATC

fluticasone, combinations; nasal

2.9

110.4

670

2796

SPAT1058

SPAT

PEF monitoring instruction

4.8

110.4

265

597

J96.1

ICD-10 Finland

Chronic respiratory failure

+∞

109.2

104

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.5

109.1

1287

7438

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

24.8

108.7

J01FA09

ATC

clarithromycin; systemic

2.7

106.8

816

3828

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

45.4

104.7

S01GX01

ATC

cromoglicic acid; ophthalmic

2.9

104.3

613

2506

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

219.1

102.3

105

R01AD11

ATC

triamcinolone; nasal

4.5

102.3

273

669

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

5.6

101.8

202

385

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

15.2

99.3

J37.0

ICD-10 Finland

Chronic laryngitis

20.9

98.8

R06AX22

ATC

ebastine; oral

3.1

97.4

498

1877

R04.2

ICD-10 Finland

Haemoptysis

10.6

97.3

108

106

TDM10

NOMESCO Finland

Puncture of maxillary antrum

134.2

96.8

103

I50.1

ICD-10 Finland

Left ventricular failure

173.5

95.9

100

RF410, ,

NOMESCO Finland

12.7

94.5

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

19.0

93.6

R06AX13

ATC

loratadine; oral

3.2

93.6

437

1560

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.4

93.0

377

1235

J47

ICD-10 Finland

Bronchiectasis

931.9

92.4

R01AC01

ATC

cromoglicic acid; nasal

6.6

88.9

147

234

Z3231

NOMESCO Finland

Registered nurse

2.5

88.3

717

3417

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

35.1

87.0

RF420, ,

NOMESCO Finland

11.3

86.1

C01CA24

ATC

epinephrine; parenteral

4.7

85.4

208

472

Z71.8

ICD-10 Finland

Other specified counselling

2.3

85.2

967

5337

UDM02

NOMESCO Finland

Sinoscopy

21.2

84.9

J36

ICD-10 Finland

Peritonsillar abscess

50.0

84.4

R5140

NOMESCO Finland

Monitoring the use of the aid

3.6

83.6

309

951

R06AE09

ATC

levocetirizine; oral

3.0

82.6

413

1527

GD1AA, ,

SPAT

2.9

82.6

464

1830

R05

ICD-10 Finland

Cough

2.7

80.4

550

2400

N02AX02

ATC

tramadol; systemic, rectal

2.3

80.3

1015

5827

XG466

NOMESCO Finland

Sleep oxymetry

9.8

79.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

14.5

79.4

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

792.6

78.8

SPAT1252

SPAT

Overall medication plan or its review

4.1

77.5

231

612

GD1AD

NOMESCO Finland

Thorax CT examination

5.8

75.5

141

253

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

119.5

75.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.4

75.0

673

3322

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

74.9

951

5434

Z00.0

ICD-10 Finland

General medical examination

2.5

74.4

579

2678

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

74.3

C07AB07

ATC

bisoprolol; oral

2.2

74.0

1089

6586

A02BC03

ATC

lansoprazole; oral

2.3

70.8

685

3483

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

707.6

70.4

A02BC05

ATC

esomeprazole; systemic

2.2

70.1

942

5471

A02BC02

ATC

pantoprazole; systemic

2.1

69.6

1578

11152

R06AX26

ATC

fexofenadine; oral

3.9

69.1

216

591

A01AB09

ATC

miconazole; local oral

3.5

69.1

256

786

R01BA52

ATC

pseudoephedrine, combinations; oral

2.3

67.9

685

3536

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.2

67.1

728

3871

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

66.5

1003

6059

R05

ICPC

Cough

2.3

66.2

620

3097

G47.3

ICD-10 Finland

Sleep apnoea

2.5

65.7

502

2289

SPAT1057

SPAT

Peak expiratory flow measurement

8.8

65.6

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

64.7

523

2445

J01FA15

ATC

telithromycin; oral

3.5

64.5

241

743

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.3

63.7

581

2864

J01MA12

ATC

levofloxacin; systemic

2.7

63.4

393

1617

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

8.3

63.4

104

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

62.2

665

3499

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

61.7

906

5385

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

15.3

61.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

61.3

254

835

N03AX12

ATC

[U] gabapentin; oral

2.7

60.4

383

1591

J01DA01

ATC

[U] cefalexin

2.0

60.2

1445

10188

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

59.9

782

4437

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

9.7

59.7

DJD20

NOMESCO Finland

Plastic repair of septum of nose

109.4

59.1

J35.2

ICD-10 Finland

Hypertrophy of adenoids

591.6

58.9

M54.5

ICD-10 Finland

Low back pain

2.0

58.6

882

5268

XG460

NOMESCO Finland

Short time oxymetry

12.1

57.5

A02BC01

ATC

omeprazole; systemic

2.2

56.7

640

3422

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

5.0

56.5

125

261

R50.9

ICD-10 Finland

Fever, unspecified

2.7

56.1

350

1440

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

10.8

56.0

R05FB02

ATC

cough suppressants and expectorants; systemic

2.0

54.5

847

5089

J01FF01

ATC

clindamycin; systemic

2.2

54.1

592

3120

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

145.7

54.0

EMB30

NOMESCO Finland

Adenotomy

9.5

52.8

R81

ICPC

Pneumonia

6.2

52.7

151

ZYC01

NOMESCO Finland

Remote contact by phone

3.5

52.7

193

586

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

52.3

C03DA01

ATC

spironolactone; oral

3.0

52.3

249

886

DHB20

NOMESCO Finland

Polypectomy of internal nose

183.9

52.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

51.8

462

2235

J01CA04

ATC

amoxicillin; systemic

2.1

51.6

1955

15747

N03AX16

ATC

[U] pregabalin

2.3

51.3

492

2454

J33.8

ICD-10 Finland

Other polyp of sinus

95.5

51.0

R03CC02

ATC

salbutamol; systemic

3.2

50.3

209

686

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

50.3

325

1357

A07AA02

ATC

nystatin; oral

3.9

49.6

153

413

R51.80

ICD-10 Finland

Headache

2.4

48.9

391

1801

SPAT1257

SPAT

Teaching of medicine inhalation technique

5.6

47.5

167

J20

ICD-10 Finland

Acute bronchitis

2.9

47.4

240

882

J01DB01

ATC

cefalexin; oral

2.0

47.0

1900

15336

L20.0

ICD-10 Finland

Besnier prurigo

2.9

46.7

231

838

SPAT1359

SPAT

Use of symptom diary

5.2

46.3

193

RF120, ,

NOMESCO Finland

8.4

45.9

201

Kela drug reimbursment

Chronic cardiac insufficiency

4.7

45.7

107

234

E0000UV, ,

ATC

1.8

45.4

999

6640

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

45.2

946

6186

J02AC01

ATC

fluconazole; systemic

1.9

44.8

897

5782

E66.01

ICD-10 Finland

Obesity due to excess calories

2.8

44.7

237

892

R05FA02

ATC

opium derivatives and expectorants; systemic

1.9

44.6

912

5917

R06.5

ICD-10 Finland

Mouth breathing

3.0

44.4

207

726

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

43.8

430

2152

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.9

43.7

134

360

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

5.7

43.5

148

ZX120

NOMESCO Finland

Intravenous

2.9

43.2

219

804

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

42.9

249

982

T78.4

ICD-10 Finland

Allergy, unspecified

3.9

42.9

129

342

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

+∞

42.8

SPAT1325

SPAT

Vaccination

1.9

42.6

817

5177

N02BE01

ATC

paracetamol; systemic, rectal

2.1

42.3

2085

17628

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.2

42.2

404

2000

N06AX21

ATC

duloxetine; oral

2.6

42.0

277

1164

R03BB02

ATC

oxitropium bromide; inhalant

55.5

41.5

Z51.6

ICD-10 Finland

Desensitization to allergens

55.5

41.5

R05CA10

ATC

expectorants - combinations

5.8

41.5

137

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.3

41.4

109

262

RF210, ,

NOMESCO Finland

4.6

41.3

100

225

R53

ICD-10 Finland

Malaise and fatigue

2.0

40.9

590

3398

J32.4

ICD-10 Finland

Chronic pansinusitis

145.8

40.9

A02BA02

ATC

ranitidine; systemic

2.2

40.8

424

2166

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

40.7

GX1E5, ,

SPAT

9.6

40.7

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

40.4

658

3946

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

66.8

40.2

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

208.3

39.9

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.1

39.8

170

566

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

15.6

39.2

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

38.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

38.6

599

3528

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.9

38.5

177

C01AA05

ATC

digoxin; systemic

3.2

38.5

163

540

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

9.9

38.3

I42.0

ICD-10 Finland

Dilated cardiomyopathy

10.2

38.1

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

135.4

37.8

J01MA02

ATC

ciprofloxacin; systemic

1.8

37.7

832

5459

D86.0

ICD-10 Finland

Sarcoidosis of lung

+∞

37.6

R60.0

ICD-10 Finland

Localized oedema

2.4

37.6

290

1307

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

37.3

321

1516

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

37.3

211

820

R28

ICPC

Limited function/disability (R)

11.3

37.1

A01AB04

ATC

amphotericin B; local oral

3.7

37.1

119

330

SPAT1254

SPAT

Administration of medicine

2.2

37.0

350

1719

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

36.2

413

2179

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.4

36.2

211

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

187.7

35.8

M79.6

ICD-10 Finland

Pain in limb

1.7

35.8

965

6682

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

35.5

R1250

NOMESCO Finland

Evaluation of functional capability

4.5

35.1

195

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

35.1

708

4507

SPAT1131

SPAT

Colonoscopy

4.0

34.8

101

261

J01DA06

ATC

[U] cefuroxime

2.2

34.7

309

1479

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

4.3

34.2

216

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

341.6

34.0

HMAK, ,

NOMESCO Finland

2.2

33.8

308

1487

R03BB07

ATC

umeclidinium bromide; inhalant

46.2

33.8

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

9.4

33.6

R29

ICPC

Respiratory symptom/complaint other

3.0

33.5

156

546

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

33.5

176

658

J96.0

ICD-10 Finland

Acute respiratory failure

+∞

33.4

H02AB09

ATC

hydrocortisone; systemic

5.4

33.1

122

N06AX16

ATC

venlafaxine; oral

2.2

33.0

315

1548

B01AA03

ATC

warfarin; systemic

2.1

32.5

352

1817

R05CB01

ATC

acetylcysteine; inhalant, oral

8.0

32.4

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

32.4

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

9.2

32.1

SPAT1263

SPAT

Sampling

1.7

32.1

920

6427

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

32.1

212

888

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

7.8

31.9

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

73.2

31.9

DHB50

NOMESCO Finland

Turbinoplasty

48.2

31.6

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

4.1

31.5

221

N05CF01

ATC

zopiclone; oral

1.8

31.3

673

4340

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

31.3

237

1057

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

39.6

31.2

J01DA09

ATC

[U] cefadroxil

1.8

31.1

569

3500

A46

ICD-10 Finland

Erysipelas

2.2

31.0

290

1412

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

31.0

399

2189

C08DA01

ATC

verapamil; systemic

3.6

30.9

105

303

G43.9

ICD-10 Finland

Migraine, unspecified

2.9

30.8

155

566

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

30.7

173

670

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

30.7

410

2279

R74

ICPC

Upper respiratory infection acute

1.7

30.4

734

4883

R42

ICD-10 Finland

Dizziness and giddiness

1.8

30.3

516

3101

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.2

30.2

120

382

M04AA01

ATC

allopurinol; systemic

2.3

29.9

247

1142

N06AX11

ATC

mirtazapine; oral

1.7

29.9

722

4797

J35.1

ICD-10 Finland

Hypertrophy of tonsils

68.8

29.9

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

29.8

226

1007

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

5.1

29.7

123

N05BA04

ATC

oxazepam; oral

1.8

29.5

582

3651

J04.0

ICD-10 Finland

Acute laryngitis

4.1

29.5

201

L28

ICPC

Limited function/disability (L)

1.9

28.9

402

2260

I45.9

ICD-10 Finland

Conduction disorder, unspecified

10.4

28.9

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

81.1

28.8

R03AC18

ATC

indacaterol; inhalant

81.1

28.8

M79.7

ICD-10 Finland

Fibromyalgia

3.9

28.8

227

P01AB01

ATC

metronidazole; oral, rectal

1.7

28.7

841

5868

AN1

Coronary angiography

2.4

28.5

203

880

N06AA09

ATC

amitriptyline; systemic

2.4

28.5

203

880

R01AC07

ATC

nedocromil; nasal

11.2

28.5

J43.9

ICD-10 Finland

Emphysema, unspecified

49.2

28.4

J01FA01

ATC

erythromycin; systemic

2.0

28.1

318

1663

M03BX02

ATC

tizanidine; oral

1.6

28.1

1300

10123

E000001, ,

ATC

1.9

28.0

440

2572

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

27.5

28.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

27.9

157

607

M48.0

ICD-10 Finland

Spinal stenosis

2.2

27.9

259

1256

S01GX02

ATC

levocabastine; ophthalmic

2.8

27.9

146

544

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.3

27.8

175

WZC30, ,

SPAT

2.3

27.7

221

1006

E000002, ,

ATC

2.2

27.7

264

1293

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

27.7

686

4574

E66.9

ICD-10 Finland

Obesity, unspecified

3.7

27.5

253

R49.08

ICD-10 Finland

Other specified dysphonia

5.3

27.2

106

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

27.1

734

5005

R07.3

ICD-10 Finland

Other chest pain

2.3

27.1

226

1049

E66.8

ICD-10 Finland

Other obesity

2.9

26.7

126

444

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

8.6

26.6

Z00.8

ICD-10 Finland

Other general examinations

2.3

26.6

209

945

SPAT1310

SPAT

Counselling related to known health issue

1.7

26.6

708

4802

I20.00

ICD-10 Finland

Unstable angina

4.4

26.5

156

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

26.1

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.2

25.9

231

1101

N06AB04

ATC

citalopram; systemic

1.8

25.8

413

2423

WQ000

NOMESCO Finland

Hyposensibilisation

73.4

25.8

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

6.5

25.6

J33.9

ICD-10 Finland

Nasal polyp, unspecified

10.1

25.6

J01DA08

ATC

[U] cefaclor

2.1

25.6

273

1396

Angiography of the heart and coronary arteries

2.8

25.4

129

473

D07AC01

ATC

betamethasone; topical

1.6

25.3

769

5381

XG405, ,

SPAT

8.3

25.3

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

5.2

25.2

102

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

25.2

198

895

N02AA05

ATC

oxycodone; systemic

1.9

25.2

359

2029

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

+∞

25.0

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

+∞

25.0

R01AD59

ATC

mometasone, combinations; nasal

2.6

24.9

152

612

D07AC13

ATC

mometasone; topical

1.7

24.8

610

4040

S18

ICPC

Laceration/cut

1.6

24.8

994

7414

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

252.6

24.7

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.1

24.7

107

359

ZXA10

NOMESCO Finland

Bilateral

1.9

24.7

354

2005

M05BA04

ATC

alendronic acid; oral

2.3

24.4

186

830

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.0

24.2

172

-1, ,

NOMESCO Finland

1.6

24.0

761

5363

L03

ICPC

Low back symptom/complaint

1.6

23.8

629

4237

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

23.7

255

1306

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.6

23.7

225

SPAT1360

SPAT

Extensive global examination

2.4

23.7

162

689

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

126.2

23.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

23.5

190

870

N05BB01

ATC

hydroxyzine; systemic

2.5

23.4

149

612

N05BA01

ATC

diazepam; systemic, rectal

2.0

23.4

264

1376

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

23.1

332

1880

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

22.9

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

3.6

22.9

211

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.9

22.9

111

397

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

22.7

157

670

R52.2

ICD-10 Finland

Other chronic pain

3.3

22.7

276

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

22.7

1235

9786

EMB20

NOMESCO Finland

Adenotonsillectomy

84.2

22.7

UJF32

NOMESCO Finland

Coloscopy

1.7

22.7

503

3234

D07AA02

ATC

hydrocortisone; topical

1.9

22.7

312

1741

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

22.5

206

992

M25.5

ICD-10 Finland

Pain in joint

1.6

22.5

677

4702

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

3.2

22.4

289

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

22.3

631

4313

Z50.5

ICD-10 Finland

Speech therapy

5.9

22.3

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

22.2

206

49099

ICD-8 Finland

Bronchitis, unspecified

8.0

22.1

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

35.4

22.1

H66.9

ICD-10 Finland

Otitis media, unspecified

2.4

22.0

156

674

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

22.0

107

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

21.9

717

5070

132

Kela drug reimbursment

Sarcoidosis

+∞

21.9

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

+∞

21.9

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

21.9

500

3236

GX2C5

NOMESCO Finland

Short-lasting oximetry

29.3

21.9

S15

ICPC

Foreign body in skin

2.3

21.8

165

733

J30.0

ICD-10 Finland

Vasomotor rhinitis

5.0

21.8

Z51.0

ICD-10 Finland

Radiotherapy session

4.6

21.7

112

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

21.7

291

1609

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

21.6

264

1415

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.6

21.5

113

R06AX11

ATC

astemizole; oral

3.3

21.5

250

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.4

21.4

236

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.9

21.3

GX1K5

NOMESCO Finland

Diffusion capacity

26.6

21.3

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

6.8

21.2

SPAT1216

SPAT

Assessment of functional ability

1.8

21.2

328

1897

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

21.2

631

4361

R83

ICPC

Respiratory infection other

1.6

21.1

570

3845

M01AE02

ATC

naproxen; oral, rectal

1.5

21.0

1226

9796

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

21.0

312

1783

R4110, ,

SPAT

1.9

20.9

303

1716

J42

ICD-10 Finland

Unspecified chronic bronchitis

16.7

20.9

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

+∞

20.9

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

20.9

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.7

20.8

111

418

Z72.0

ICD-10 Finland

Tobacco use

4.7

20.8

104

SPAT1301

SPAT

No procedures

1.6

20.8

662

4644

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

37.5

20.8

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

20.7

372

2250

J01DC02

ATC

cefuroxime; systemic

2.7

20.5

110

415

N06AB03

ATC

fluoxetine; oral

2.0

20.5

255

1374

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

20.5

176

826

N05AH04

ATC

quetiapine; oral

1.8

20.4

357

2142

N05CD07

ATC

temazepam; oral

2.0

20.4

232

1211

A03FA02

ATC

cisapride; oral, rectal

2.3

20.4

165

755

J01.1

ICD-10 Finland

Acute frontal sinusitis

7.5

20.4

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.2

20.3

172

802

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

20.2

302

1727

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

20.0

274

1523

SPAT1260

SPAT

Consultation of another employee

1.8

20.0

353

2123

K77

ICPC

Heart failure

6.8

20.0

A06AD11

ATC

lactulose; oral

1.9

19.8

295

1686

R49.01

ICD-10 Finland

Functional dysphonia

3.6

19.8

179

A03

ICPC

Fever

1.8

19.8

353

2130

N03AX09

ATC

lamotrigine; oral

2.8

19.6

362

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

19.6

195

969

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

19.6

388

2410

RP210, ,

NOMESCO Finland

105.9

19.6

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

19.5

228

1202

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.7

19.4

167

XA402

NOMESCO Finland

ENMG

3.7

19.4

167

GX1C5, ,

SPAT

15.7

19.3

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

5.0

19.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

19.2

278

1573

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

19.2

425

2720

SPAT1255

SPAT

Intravenous administration of medicine

2.5

19.2

127

532

SPAT1240

SPAT

Therapeutic discussion

2.0

19.1

235

1260

S01GX08

ATC

ketotifen; ophthalmic

2.6

19.1

108

419

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

55.4

18.9

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.8

18.9

283

1618

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

18.8

614

4316

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

18.8

204

1047

DPA30

NOMESCO Finland

Sphenotomy

+∞

18.8

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

18.8

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

+∞

18.8

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

18.8

V01AA05

ATC

tree pollen; parenteral

7.7

18.7

G44.2

ICD-10 Finland

Tension-type headache

1.9

18.6

273

1550

B01AC04

ATC

clopidogrel; oral

1.8

18.6

291

1687

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

18.6

163

771

M01AH02

ATC

rofecoxib; oral

1.9

18.5

239

1302

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.0

18.5

274

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

18.4

228

1225

A12BA01

ATC

potassium chloride; oral

3.0

18.4

280

I50

ICD-10 Finland

Heart failure

5.9

18.4

M10.9

ICD-10 Finland

Gout, unspecified

2.5

18.3

121

507

PLAK0, ,

NOMESCO Finland

5.6

18.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

18.1

322

1937

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

18.1

826

6226

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

18.1

251

1401

C01BD01

ATC

amiodarone; systemic

4.3

18.1

108

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

18.0

211

1112

OAB71, ,

SPAT

5.9

17.9

207

Kela drug reimbursment

Chronic arrhythmias

1.9

17.8

255

1437

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

4.7

17.7

I47.2

ICD-10 Finland

Ventricular tachycardia

4.7

17.7

D07BC01

ATC

betamethasone and antiseptics; topical

1.9

17.7

236

1299

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

+∞

17.7

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

+∞

17.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

17.7

H65.3

ICD-10 Finland

Chronic mucoid otitis media

3.9

17.6

132

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

29.0

17.4

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

17.3

343

2127

WW200

NOMESCO Finland

Immunization

3.6

17.3

157

R1250, ,

SPAT

2.8

17.2

324

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

17.2

308

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.6

17.2

101

400

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.5

17.1

107

436

WX308

NOMESCO Finland

Sacral anesthesy

16.0

17.0

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

17.0

310

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

17.5

16.9

RF220, ,

NOMESCO Finland

5.0

16.9

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

16.8

106

434

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

16.7

424

2800

WZC00, ,

SPAT

1.7

16.7

335

2083

348

Kela drug reimbursment

Roflumilast

+∞

16.7

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

+∞

16.7

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

+∞

16.7

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

+∞

16.7

R21

ICPC

Throat symptom/complaint

1.6

16.6

453

3043

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

16.6

960

7542

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

16.6

379

2437

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.4

16.5

120

524

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

16.4

143

674

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

16.4

853

6565

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

16.3

866

6692

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.0

16.3

245

N02BF01

ATC

gabapentin; oral

1.9

16.2

197

1052

R2110

NOMESCO Finland

Giving the first information

2.2

16.2

137

639

X58

ICD-10 Finland

Exposure to other specified factors

1.7

16.2

295

1786

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

30.2

16.1

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.7

16.1

342

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

5.3

16.1

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

16.0

482

3314

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.1

15.9

211

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.5

15.9

103

427

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

15.9

221

1233

SPAT1097

SPAT

Recording of ECG

1.8

15.9

272

1617

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

15.9

472

3234

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

60.4

15.8

R5110, ,

SPAT

2.0

15.8

176

912

E000003, ,

ATC

2.6

15.8

381

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

15.8

15.7

R52.9

ICD-10 Finland

Pain, unspecified

1.9

15.7

205

1121

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

15.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

15.6

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

15.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

15.6

R06AX12

ATC

terfenadine; oral

2.5

15.5

390

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

15.5

303

1869

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

160.9

15.5

Z08

ICPC

Social welfare problem

4.7

15.4

RF421, ,

NOMESCO Finland

6.7

15.3

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

15.3

142

687

A02BA04

ATC

nizatidine; systemic

2.1

15.3

144

701

M01AH05

ATC

etoricoxib; oral

1.4

15.3

1257

10467

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

15.3

375

ZXC60

NOMESCO Finland

Application of heat

7.0

15.3

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.9

15.2

S06.0

ICD-10 Finland

Concussion

1.9

15.2

217

1220

M79.1

ICD-10 Finland

Myalgia

1.7

15.2

299

1848

N06AB10

ATC

escitalopram; oral

1.6

15.1

415

2789

D11AH01

ATC

tacrolimus; topical

5.7

15.1

N03AE01

ATC

clonazepam; systemic

2.4

15.0

104

445

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

15.0

348

2244

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.2

15.0

193

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

5.4

14.9

C10AA01

ATC

simvastatin; oral

1.4

14.9

772

5913

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

14.9

275

1670

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

14.8

225

1290

R03AC19

ATC

olodaterol

31.9

14.8

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

14.7

250

1481

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

6.1

14.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

14.6

228

1317

KHV, ,

NOMESCO Finland

5.7

14.6

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

14.6

J94.8

ICD-10 Finland

Other specified pleural conditions

80.6

14.6

E000006, ,

ATC

2.1

14.6

132

633

TQW80

NOMESCO Finland

Local dermatologic skincare

3.0

14.5

207

N07BA03

ATC

varenicline; oral

2.6

14.5

313

R11

ICD-10 Finland

Nausea and vomiting

1.9

14.5

175

932

N06AA12

ATC

doxepin; systemic

2.4

14.5

409

J38.2

ICD-10 Finland

Nodules of vocal cords

150.8

14.5

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

150.8

14.5

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

150.8

14.5

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.1

14.5

197

M05BA07

ATC

risedronic acid; oral

2.9

14.5

229

J30.19

ICD-10 Finland

Pollen allergy UNS

2.5

14.4

385

C08DB01

ATC

diltiazem; oral

2.3

14.4

106

466

R07

ICPC

Sneezing/nasal congestion

2.1

14.4

135

656

S22.3

ICD-10 Finland

Fracture of rib

2.1

14.3

138

677

I20.09

ICD-10 Finland

Unstable angina

2.4

14.3

417

C01DA14

ATC

isosorbide mononitrate; oral

1.7

14.3

271

1657

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

27.3

14.3

P76

ICPC

Depressive disorder

2.1

14.2

143

713

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.9

14.2

106

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

14.1

115

528

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.0

14.1

200

K07

ICPC

Swollen ankles/oedema

2.5

14.1

359

J15.8

ICD-10 Finland

Other bacterial pneumonia

42.7

14.1

R03BA07

ATC

mometasone; inhalant

6.4

14.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

14.1

109

490

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

14.1

428

2940

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

14.0

422

2892

WX722

NOMESCO Finland

PEEP

2.9

14.0

228

N02BF02

ATC

pregabalin; oral

2.2

14.0

119

557

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.7

13.9

285

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.9

13.9

218

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

13.9

230

1353

H57.1

ICD-10 Finland

Ocular pain

2.5

13.9

362

G43.3

ICD-10 Finland

Complicated migraine

3.8

13.9

108

R03

ICPC

Wheezing

6.0

13.9

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

13.8

176

954

E000007, ,

ATC

2.2

13.8

114

527

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

23.9

13.8

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.9

13.8

104

SPAT1153

SPAT

Removal of sutures

1.5

13.8

601

4447

C07AB05

ATC

betaxolol; oral

3.0

13.8

203

UDC00

NOMESCO Finland

Ear microscopy

2.1

13.7

133

654

XA420

NOMESCO Finland

Extensive sleep examination

6.3

13.7

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

13.7

151

779

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

13.7

416

2856

A02BX02

ATC

sucralfate; oral

2.5

13.6

335

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

13.6

377

2535

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.0

13.6

210

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

13.5

1350A

ICD-9 Finland

Sarcoidosis[SARCOIDOSIS]

+∞

13.5

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

13.5

R03DX07

ATC

roflumilast; oral

+∞

13.5

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

13.5

C08CA13

ATC

lercanidipine; oral

1.7

13.5

282

1767

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

5.5

13.5

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.9

13.5

101

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.4

13.5

367

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

140.7

13.5

J32.1

ICD-10 Finland

Chronic frontal sinusitis

140.7

13.5

J92.9

ICD-10 Finland

Pleural plaque without asbestos

140.7

13.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

13.5

496

3547

R06

ICD-10 Finland

Abnormalities of breathing

5.2

13.4

WW200, ,

SPAT

1.4

13.4

624

4670

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

13.4

197

1118

I45.8

ICD-10 Finland

Other specified conduction disorders

11.5

13.3

E66.0

ICD-10 Finland

Obesity due to excess calories

5.3

13.2

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.3

13.2

102

459

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

13.1

428

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

13.1

259

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.9

13.1

209

XG422, ,

SPAT

15.1

13.1

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.0

13.1

143

736

280

Kela drug reimbursment

Clopidogrel

4.5

13.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

13.0

808

6359

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

13.0

536

3915

D07AB08

ATC

desonide; topical

1.8

13.0

210

1226

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.5

13.0

337

R03AC04

ATC

fenoterol; inhalant

28.5

13.0

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.3

12.9

424

S80.0

ICD-10 Finland

Contusion of knee

1.9

12.9

153

809

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

12.9

246

1504

M02AA07

ATC

piroxicam; topical

1.4

12.9

668

5091

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

12.9

173

954

B37.08

ICD-10 Finland

Other candidal stomatitis

5.6

12.9

ZX100

NOMESCO Finland

Oral

4.4

12.9

Y0499

ICD-8 Finland

Investigation of respiratory system

4.9

12.8

GDC00

NOMESCO Finland

Lobectomy of lung

50.2

12.8

N02AA01

ATC

morphine; systemic, rectal

3.8

12.8

105

C08CA01

ATC

amlodipine; oral

1.4

12.8

699

5379

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

11.6

12.8

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

9.7

12.7

XQ848

NOMESCO Finland

Dermatological photography

2.6

12.7

269

H92.0

ICD-10 Finland

Otalgia

2.0

12.7

134

681

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

12.7

213

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

12.6

108

507

GX1D5

NOMESCO Finland

Flow volume spirometry

32.2

12.6

V01AA02

ATC

grass pollen; parenteral

32.2

12.6

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

4.1

12.6

RD210, ,

NOMESCO Finland

3.8

12.5

102

R09

ICPC

Sinus symptom/complaint

1.9

12.5

150

797

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

12.5

G04CA02

ATC

tamsulosin; oral

1.5

12.5

411

2866

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

12.5

105

489

R01AX03

ATC

ipratropium bromide; nasal

3.5

12.5

126

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

12.4

230

1395

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

130.6

12.4

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

130.6

12.4

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

4.9

12.4

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.2

12.3

152

A02BC04

ATC

rabeprazole; oral

1.9

12.3

157

852

D02AE01

ATC

carbamide; topical

2.1

12.2

122

608

J01EA01

ATC

trimethoprim; systemic

1.5

12.2

528

3891

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

12.1

141

741

L27.2

ICD-10 Finland

Dermatitis due to ingested food

4.9

12.1

J05AB01

ATC

aciclovir; systemic

1.5

12.1

422

2978

R04

ICPC

Breathing problem other

2.5

12.1

324

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

12.1

100

463

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

12.1

288

K59.0

ICD-10 Finland

Constipation

2.1

12.0

112

543

XG430

NOMESCO Finland

Spiroegometry

26.8

12.0

C09CA06

ATC

candesartan; oral

1.5

12.0

448

3206

R05CB02

ATC

bromhexine; systemic

4.0

11.9

P29

ICPC

Psychological sympt/compl other

1.8

11.9

167

934

D07AD01

ATC

clobetasol; topical

1.6

11.9

321

2141

RJ190, ,

NOMESCO Finland

46.9

11.9

C09CA01

ATC

losartan; oral

1.5

11.9

471

3410

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.1

11.8

L01

ICPC

Neck symptom/complaint

1.6

11.8

326

2185

PLAK1, ,

NOMESCO Finland

3.9

11.8

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.7

11.8

252

1588

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

11.8

183

1056

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

11.8

735

5772

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.1

11.7

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

9.7

11.7

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

11.7

473

3436

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

4.9

11.7

N04BC05

ATC

pramipexole; oral

2.0

11.7

136

716

L50.0

ICD-10 Finland

Allergic urticaria

2.7

11.6

223

R5120

NOMESCO Finland

Preparation of an aid

2.6

11.6

246

J01.4

ICD-10 Finland

Acute pansinusitis

30.2

11.6

J98.1

ICD-10 Finland

Pulmonary collapse

65.2

11.6

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

11.6

393

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

11.6

294

N06AX12

ATC

bupropion; oral

1.9

11.6

136

718

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

11.6

445

RF430, ,

NOMESCO Finland

11.1

11.5

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.2

11.5

143

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

11.5

143

K05

ICPC

Irregular heartbeat other

2.4

11.5

313

250, ,

Kela drug reimbursment

8.6

11.5

R39

ICPC

Respiratory, Physical function test

8.6

11.5

S97

ICPC

Chronic ulcer skin

2.2

11.5

101

479

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

+∞

11.5

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

+∞

11.5

S01ED02

ATC

betaxolol; ophthalmic

5.0

11.5

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

11.4

320

SPAT1098

SPAT

Exercise ECG

3.1

11.4

154

J98.6

ICD-10 Finland

Disorders of diaphragm

120.5

11.4

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

11.4

231

1435

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

11.4

149

815

M01AC06

ATC

meloxicam; systemic, rectal

1.4

11.4

675

5249

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.9

11.4

192

S16

ICPC

Bruise/contusion

2.5

11.3

273

N03AG01

ATC

valproic acid; systemic, rectal

2.1

11.3

101

482

R03DA05

ATC

aminophylline; systemic, rectal

8.3

11.3

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

11.3

108

530

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

35.2

11.3

4222

FHL

Endonasal etmoidectomy

10.6

11.3

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

11.2

354

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

11.2

204

1232

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.4

11.2

311

M54.1

ICD-10 Finland

Radiculopathy

2.4

11.2

330

J38.3

ICD-10 Finland

Other diseases of vocal cords

25.1

11.1

D11AH05

ATC

dupilumab; topical

25.1

11.1

A01

ICPC

Pain general/multiple sites

1.8

11.1

181

1059

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

11.1

356

M01AH01

ATC

celecoxib; oral

1.6

11.1

316

2134

M54.3

ICD-10 Finland

Sciatica

2.0

11.1

113

568

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.3

11.0

338

N02AC04

ATC

dextropropoxyphene; oral

2.4

11.0

301

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.8

11.0

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

4.3

11.0

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.7

11.0

224

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

10.1

11.0

R06AX18

ATC

acrivastine; oral

2.8

11.0

185

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.6

10.9

248

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.8

10.9

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.9

10.8

148

821

Z3226

NOMESCO Finland

Physiotherapist

1.6

10.8

297

1987

B02AA02

ATC

tranexamic acid; systemic

1.6

10.8

279

1840

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

10.8

418

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.2

10.8

EB1VA, ,

NOMESCO Finland

1.5

10.8

349

2421

L04AX01

ATC

azathioprine; systemic

2.4

10.8

298

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

10.8

184

1092

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

10.8

1534

13585

S76

ICPC

Skin infection other

2.1

10.7

100

486

P01

ICPC

Feeling anxious/nervous/tense

1.6

10.7

281

1861

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

10.7

143

788

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

10.7

121

631

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.7

10.7

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

10.7

165

951

H01

ICPC

Ear pain/earache

1.6

10.7

231

1461

N05BA12

ATC

alprazolam; oral

1.7

10.6

178

1050

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.3

10.6

331

K30

ICD-10 Finland

Functional dyspepsia

1.7

10.6

214

1328

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

60.2

10.6

H65.2

ICD-10 Finland

Chronic serous otitis media

4.2

10.6

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

10.6

252

R13

ICD-10 Finland

Dysphagia

2.0

10.6

117

605

J32

ICD-10 Finland

Chronic sinusitis

11.2

10.5

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

10.5

247

N05CF02

ATC

zolpidem; oral

1.5

10.5

306

2075

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

9.2

10.5

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

10.5

220

1380

C09CA03

ATC

valsartan; oral

1.8

10.5

160

919

P03

ICPC

Feeling depressed

1.7

10.5

209

1294

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

110.4

10.4

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

110.4

10.4

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

10.4

152

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

+∞

10.4

J43.8

ICD-10 Finland

Other emphysema

+∞

10.4

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

10.4

M54.2

ICD-10 Finland

Cervicalgia

1.8

10.4

153

869

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.9

10.4

C07AA05

ATC

propranolol; systemic

1.5

10.4

379

2695

ZX108, ,

SPAT

16.1

10.3

RF310, ,

NOMESCO Finland

16.1

10.3

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

10.3

466

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

32.6

10.3

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

10.3

305

2076

A11CC03

ATC

alfacalcidol; systemic

3.3

10.3

117

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.4

10.3

ZX140

NOMESCO Finland

Intra articular

4.9

10.3

S01GX06

ATC

emedastine; ophthalmic

4.0

10.2

EBA00

NOMESCO Finland

Extraction of tooth

1.4

10.2

753

6046

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

10.2

435

JN4AD

NOMESCO Finland

Body CT examination

1.7

10.1

175

1042

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.8

10.1

171

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

10.1

100

497

205

Kela drug reimbursment

Chronic hypertension

1.4

10.1

496

3727

AN2

Balloon angioplasty, including several vessels

2.7

10.1

194

R05DB05

ATC

pentoxyverine; oral, rectal

2.4

10.0

271

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

5.0

10.0

SPAT1229

SPAT

Assessment of need for aid

1.9

10.0

128

696

J05AH02

ATC

oseltamivir; oral

9.2

10.0

ZX108

NOMESCO Finland

Inhalation

14.6

10.0

ZX114

NOMESCO Finland

Intramuscular

3.7

10.0

J96.9

ICD-10 Finland

Respiratory failure, unspecified

40.2

10.0

N06AX03

ATC

mianserin; oral

2.2

9.9

393

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

9.9

354

N06AX26

ATC

vortioxetine; oral

1.8

9.9

154

889

A10BA02

ATC

metformin; oral

1.4

9.9

504

3807

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

9.9

137

764

A28

ICPC

Limited function/disability NOS

1.5

9.9

305

2093

Z01.2

ICD-10 Finland

Dental examination

1.3

9.9

978

8188

UJC12

NOMESCO Finland

Flexible oesophagoscopy

8.1

9.8

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

9.8

118

629

UJD02

NOMESCO Finland

Gastroscopy

2.2

9.8

402

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.1

9.7

470

ZY010

NOMESCO Finland

Hospital outpatient

2.1

9.7

470

R78

ICPC

Acute bronchitis/bronchiolitis

3.3

9.7

111

R55

ICD-10 Finland

Syncope and collapse

1.7

9.7

199

1241

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.3

9.7

313

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.4

9.7

276

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

55.2

9.6

J38.4

ICD-10 Finland

Oedema of larynx

55.2

9.6

R52.1

ICD-10 Finland

Chronic intractable pain

5.3

9.6

D02AX

ATC

Other emollients and protectives

2.5

9.6

240

4226

FHL

Posterior radical surgery and possible etmoidectomy

7.8

9.6

SPAT1251

SPAT

Organisation of medication

2.4

9.6

277

48509

ICD-8 Finland

Bronchopneumonia, unspecified

4.3

9.6

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

9.6

149

861

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

9.6

171

1028

ND2AA, ,

SPAT

2.0

9.5

105

543

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.8

9.5

R43

ICPC

Respiratory, Other diagnostic procedure

9.1

9.5

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

9.5

266

SPAT1262

SPAT

Handing over of treatment supplies

1.5

9.5

280

1903

WX723

NOMESCO Finland

CPAP therapy

2.2

9.5

355

ZX112

NOMESCO Finland

Subcutaneous

3.0

9.5

139

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

9.5

242

H03AA01

ATC

levothyroxine sodium; systemic

1.4

9.5

432

3200

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.0

9.5

496

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

9.4

265

1782

J01

ICD-10 Finland

Acute sinusitis

2.1

9.4

449

UDQ02

NOMESCO Finland

Direct laryngoscopy

7.6

9.4

4239

FHL

Other measure in this category

17.6

9.4

J93.8

ICD-10 Finland

Other pneumothorax

+∞

9.4

J93.9

ICD-10 Finland

Pneumothorax, unspecified

+∞

9.4

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

9.4

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

+∞

9.4

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

9.4

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

9.4

242

1596

JN3AE, ,

SPAT

2.1

9.4

396

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

9.3

124

683

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.4

9.3

262

48609

ICD-8 Finland

Pneumonia, unspecified

3.8

9.3

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

9.3

132

742

4224

FHL

Endonasal anthrostomy

6.9

9.3

WYA00, ,

SPAT

3.3

9.3

104

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.5

9.3

232

SPAT1236

SPAT

Informing family of child’s disability

2.8

9.3

168

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.0

9.2

103

535

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

3.0

9.2

136

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.2

9.2

115

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

9.2

110

P17

ICPC

Tobacco abuse

3.9

9.1

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

2.3

9.1

296

R01AC02

ATC

levocabastine; nasal

2.7

9.1

187

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

3.1

9.1

121

Z50.1

ICD-10 Finland

Other physical therapy

2.0

9.1

469

N39.3

ICD-10 Finland

Stress incontinence

1.8

9.1

139

800

C09AA02

ATC

enalapril; systemic

1.5

9.1

337

2401

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.1

9.0

415

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

9.0

175

1075

M02AA10

ATC

ketoprofen; topical

1.5

9.0

285

1964

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

9.0

402

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

9.0

464

L50.9

ICD-10 Finland

Urticaria, unspecified

2.2

9.0

350

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.2

9.0

337

N02AJ13

ATC

tramadol and paracetamol; systemic

2.8

9.0

149

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

9.0

513

D09AB01

ATC

zinc bandage without supplements; topical

3.1

8.9

117

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

8.9

465

A02BA03

ATC

famotidine; systemic

2.3

8.9

280

L16

ICPC

Ankle symptom/complaint

1.6

8.9

233

1541

R03BB05

ATC

aclidinium bromide; inhalant

24.1

8.9

395

Kela drug reimbursment

Dupilumab

24.1

8.9

R03DB04

ATC

theophylline and adrenergics; systemic

24.1

8.9

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

8.9

508

3905

R4110

NOMESCO Finland

Physiotherapy

1.4

8.9

460

3479

A04

ICPC

Weakness/tiredness general

1.5

8.9

300

2097

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

8.0

8.8

EB1HA, ,

SPAT

2.4

8.8

250

R5599

NOMESCO Finland

Other rehabilitation service

2.4

8.8

244

OAB42, ,

SPAT

1.5

8.8

277

1907

DFF15

NOMESCO Finland

Speech audiometry

2.0

8.8

516

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

8.8

220

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

8.8

468

XKD00

NOMESCO Finland

Uroflowmetry

1.5

8.8

266

1818

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.4

8.8

H15.1

ICD-10 Finland

Episcleritis

3.4

8.8

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

8.7

245

R25.2

ICD-10 Finland

Cramp and spasm

2.7

8.7

168

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

7.2

8.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

8.7

394

N02CC06

ATC

eletriptan; oral

2.2

8.7

322

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

50.1

8.7

D72.1

ICD-10 Finland

Eosinophilia

50.1

8.7

R23

ICPC

Voice symptom/complaint

2.7

8.7

163

M01AX17

ATC

nimesulide; oral

1.4

8.7

402

2983

M35.7

ICD-10 Finland

Hypermobility syndrome

3.5

8.6

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.3

8.6

259

A01AB10

ATC

natamycin; local oral

2.3

8.6

259

R05DA01

ATC

ethylmorphine; oral

1.8

8.6

133

767

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.4

8.6

S20.2

ICD-10 Finland

Contusion of thorax

2.0

8.6

492

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

8.6

184

1160

A92

ICPC

Allergy/allergic reaction NOS

2.3

8.6

272

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.8

8.6

147

S19

ICPC

Skin injury other

2.1

8.6

370

RF313, ,

NOMESCO Finland

16.3

8.5

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

8.5

216

1418

RJ411, ,

NOMESCO Finland

9.0

8.5

50708

ICD-8 Finland

Hay fever, Alia definita

9.0

8.5

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.8

8.5

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

8.5

419

3141

AA1AD

NOMESCO Finland

CT of head and brain

1.4

8.5

478

3663

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.0

8.5

126

Z51.5

ICD-10 Finland

Palliative care

1.8

8.5

134

779

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

20.1

8.5

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

8.5

187

1189

ZX109, ,

SPAT

7.4

8.4

J86.9

ICD-10 Finland

Pyothorax without fistula

90.3

8.4

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

90.3

8.4

R03BB06

ATC

glycopyrronium bromide; inhalant

90.3

8.4

DMB10

NOMESCO Finland

Radical maxillary antrotomy

90.3

8.4

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

90.3

8.4

A10BJ06

ATC

semaglutide; parenteral

2.0

8.4

420

M43.1

ICD-10 Finland

Spondylolisthesis

2.1

8.4

346

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.6

8.4

189

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.1

8.4

353

P06

ICPC

Sleep disturbance

1.6

8.4

226

1505

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.8

8.4

149

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.8

8.4

116

648

RJ410, ,

NOMESCO Finland

12.8

8.4

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

8.3

228

1523

H65.0

ICD-10 Finland

Acute serous otitis media

3.0

8.3

122

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

8.3

3028

Kela drug reimbursment

Mepolizumab

+∞

8.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

8.3

51899

ICD-8 Finland

Bronchiectasis

+∞

8.3

3027

Kela drug reimbursment

Benralizumab

+∞

8.3

TGA30

NOMESCO Finland

Thoracocentesis

+∞

8.3

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

8.3

251, ,

Kela drug reimbursment

+∞

8.3

49308

ICD-8 Finland

Asthma, Alia definita

+∞

8.3

R03DX10

ATC

benralizumab; systemic

+∞

8.3

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

8.3

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

8.3

505

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

8.3

104

562

B34.9

ICD-10 Finland

Viral infection, unspecified

2.4

8.3

226

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

8.3

123

701

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

8.3

204

1330

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

8.5

8.3

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

8.3

187

1195

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

8.3

127

732

J41.0

ICD-10 Finland

Simple chronic bronchitis

9.5

8.3

RF110, ,

NOMESCO Finland

9.5

8.3

C02DE01, ,

ATC

4.1

8.3

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

8.2

349

N03AF01

ATC

carbamazepine; oral, rectal

2.0

8.2

410

N30.0

ICD-10 Finland

Acute cystitis

1.4

8.2

333

2411

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

8.2

N06AX22

ATC

agomelatine; oral

2.6

8.2

168

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

14.5

8.2

R10.0

ICD-10 Finland

Acute abdomen

2.3

8.2

259

R01BA01

ATC

phenylpropanolamine; oral

2.0

8.2

459

L04AX03

ATC

methotrexate; systemic

1.7

8.2

157

963

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

8.2

318

2284

SPAT1283

SPAT

Restricted health certificate

1.4

8.2

319

2293

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

8.2

234

1580

R60.1

ICD-10 Finland

Generalized oedema

7.5

8.1

R07.0

ICD-10 Finland

Pain in throat

1.8

8.1

130

759

GEA00

NOMESCO Finland

Mediastinoscopy

33.4

8.1

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

33.4

8.1

XKX00

NOMESCO Finland

Pelvic floor electromyography

8.1

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

17.2

8.1

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

8.1

1080

9331

315

Kela drug reimbursment

Clopidogrel

4.0

8.1

XF640, ,

NOMESCO Finland

2.6

8.0

176

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.0

8.0

435

ZXA05

NOMESCO Finland

Left side

1.4

8.0

403

3031

L04AA01

ATC

[U] ciclosporin

4.1

8.0

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

8.0

160

993

P25

ICPC

Phase of life problem adult

2.0

7.9

436

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

3.4

7.9

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

3.2

7.9

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.3

7.9

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

7.9

150

917

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

13.1

7.9

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.1

7.9

349

S01

ICPC

Pain/tenderness of skin

2.0

7.8

439

SPAT1211

SPAT

Application of soft bandage

1.6

7.8

158

983

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

7.8

134

798

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

7.8

254

1762

K02.1

ICD-10 Finland

Caries of dentine

1.3

7.8

1206

10591

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

9.4

7.8

F02

ICPC

Red eye

1.9

7.8

461

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

7.8

114

649

L15

ICPC

Knee symptom/complaint

1.4

7.8

484

3766

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

7.7

358

XQ802

NOMESCO Finland

Epicutan test

2.1

7.7

338

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

15.1

7.7

XF404

NOMESCO Finland

Ambulatory ECG

1.7

7.7

127

748

T91

ICPC

Vitamin/nutritional deficiency

4.3

7.7

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

3.2

7.7

NF1AA, ,

SPAT

2.0

7.7

442

3007

Kela drug reimbursment

Erenumab and fremanezumab

3.3

7.7

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

7.6

267

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

7.6

309

2236

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

7.6

242

F03

ICPC

Eye discharge

1.7

7.6

130

773

ZXA00

NOMESCO Finland

Right side

1.4

7.6

432

3311

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

18.4

7.6

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

7.6

136

820

RJ421, ,

NOMESCO Finland

11.9

7.6

RS221, ,

NOMESCO Finland

3.6

7.6

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

25.1

7.6

OAB91, ,

SPAT

1.7

7.6

131

782

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

7.6

580

4651

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

8.9

7.5

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

7.5

212

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

7.5

431

R06.4

ICD-10 Finland

Hyperventilation

3.3

7.5

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

7.5

141

861

R06AE08, ,

ATC

4.2

7.5

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

7.5

257

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

7.5

336

Z2445

NOMESCO Finland

Psychologist

2.1

7.4

350

SPAT1267

SPAT

Desensitisation

80.3

7.4

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

80.3

7.4

Z01.7

ICD-10 Finland

Laboratory examination

1.4

7.4

317

2316

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

7.4

163

1036

E66

ICD-10 Finland

Obesity

1.9

7.4

505

N05AF03

ATC

chlorprothixene; systemic

2.6

7.4

154

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

7.4

117

682

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.6

7.3

166

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

7.3

101

564

R04.0

ICD-10 Finland

Epistaxis

1.7

7.3

117

683

S01GX04

ATC

nedocromil; ophthalmic

2.9

7.3

115

R49.0

ICD-10 Finland

Dysphonia

2.9

7.3

115

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

7.3

485

N02CC04

ATC

rizatriptan; oral

1.8

7.3

543

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

+∞

7.3

13599

ICD-8 Finland

Sarcoidosis, Unspecified

+∞

7.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

7.3

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

7.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

R03DX09

ATC

mepolizumab; parenteral

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

7.3

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

7.3

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

7.3

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.8

7.2

127

P01BA02

ATC

hydroxychloroquine; oral

1.7

7.2

127

762

L50.8

ICD-10 Finland

Other urticaria

2.9

7.2

116

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

5.8

7.2

PA6AD

NOMESCO Finland

CT of neck arteries

2.1

7.2

334

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

3.7

7.2

A06AC51

ATC

ispaghula, combinations; oral

2.0

7.2

403

A10BK01

ATC

dapagliflozin; oral

1.8

7.2

112

650

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

7.1

229

1583

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

30.1

7.1

J12.8

ICD-10 Finland

Other viral pneumonia

30.1

7.1

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

30.1

7.1

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

7.1

1482

13410

XQ902

NOMESCO Finland

Other photography

3.6

7.1

B01AB05

ATC

enoxaparin; parenteral

1.3

7.1

527

4199

RJ511, ,

NOMESCO Finland

20.1

7.1

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

20.1

7.1

UKC02

NOMESCO Finland

Cystoscopy

1.5

7.1

263

1870

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.4

7.1

374

2830

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.8

7.1

117

R05CB03

ATC

carbocisteine; oral

2.6

7.1

157

J05AB11

ATC

valaciclovir; oral

1.5

7.1

252

1778

S81.0

ICD-10 Finland

Open wound of knee

2.7

7.1

134

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.1

765

6410

J38.7

ICD-10 Finland

Other diseases of larynx

12.0

7.1

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

7.1

185

1225

L86

ICPC

Back syndrome with radiating pain

1.8

7.0

106

609

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

7.0

463

J06.0

ICD-10 Finland

Acute laryngopharyngitis

4.2

7.0

KMAK, ,

NOMESCO Finland

1.3

7.0

992

8586

N01

ICPC

Headache

1.5

7.0

222

1533

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

7.0

450

Z01.3

ICD-10 Finland

Examination of blood pressure

3.0

7.0

102

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.8

7.0

124

D01AE15

ATC

terbinafine; topical

1.7

7.0

118

701

PE1AT

NOMESCO Finland

Femoral artery PTA

4.4

7.0

L12

ICPC

Hand/finger symptom/complaint

1.4

6.9

317

2342

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

6.9

230

1601

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

6.9

103

589

OAB93, ,

SPAT

1.7

6.9

115

679

I49.5

ICD-10 Finland

Sick sinus syndrome

2.2

6.9

246

D06AX01

ATC

fusidic acid; topical

1.6

6.9

165

1070

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

6.9

395

L01CA04

ATC

vinorelbine; systemic

7.5

6.9

A10BX04

ATC

[U] exenatide

4.0

6.9

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

6.9

197

1331

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.2

6.9

260

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

6.9

100

569

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

6.8

172

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

6.8

231

1615

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.3

6.8

Z48.8

ICD-10 Finland

Other specified surgical follow-up care

4.1

6.8

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

3.8

6.8

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.1

6.8

281

N03AX11

ATC

topiramate; oral

2.5

6.8

167

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

40.1

6.8

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

40.1

6.8

C08CA05

ATC

nifedipine; systemic

1.7

6.7

107

624

Z29.0

ICD-10 Finland

Isolation

16.7

6.7

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

6.7

329

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.0

6.7

364

A10BJ02

ATC

liraglutide; parenteral

2.4

6.7

186

N02CD01

ATC

erenumab; parenteral

3.9

6.7

SPAT1324

SPAT

Screening procedure

1.4

6.7

324

2417

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.2

6.7

RK112, ,

NOMESCO Finland

22.6

6.7

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

22.6

6.7

K07.60

ICD-10 Finland

Snapping jaw

1.8

6.7

493

OAA65, ,

SPAT

1.4

6.7

327

2446

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.7

6.6

NG1AA, ,

SPAT

1.6

6.6

145

921

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

6.6

450

3540

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

4.0

6.6

C08CA02

ATC

felodipine; oral

1.6

6.6

154

993

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

6.6

110

651

R03CC03

ATC

terbutaline; systemic

2.3

6.6

219

OAB44

NOMESCO Finland

General health guidance

12.3

6.6

R75

ICPC

Sinusitis acute/chronic

2.0

6.6

360

M01AB55

ATC

diclofenac, combinations; oral

1.7

6.5

106

622

S30.1

ICD-10 Finland

Contusion of abdominal wall

3.0

6.5

M05BX04

ATC

denosumab; parenteral

1.7

6.5

103

600

UDQ22

NOMESCO Finland

Microlaryngoscopy

10.0

6.5

R00.2

ICD-10 Finland

Palpitations

1.6

6.5

141

893

K78

ICPC

Atrial fibrillation/flutter

1.7

6.5

103

601

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.8

6.5

112

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

3.7

6.5

B82

ICPC

Anaemia other/unspecified

2.2

6.5

221

B01AF02

ATC

apixaban; oral

1.5

6.5

193

1316

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

6.4

154

999

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

6.4

154

999

S01GX09

ATC

olopatadine; ophthalmic

2.2

6.4

234

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

3.5

6.4

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.6

6.4

159

1040

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

70.0

6.4

NOMESCO Finland

Other rehabilitation services

70.0

6.4

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

70.0

6.4

RJ422, ,

NOMESCO Finland

70.0

6.4

D10

ICPC

Vomiting

1.7

6.4

111

664

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

6.4

485

K08.3

ICD-10 Finland

Retained dental root

1.7

6.4

122

749

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.2

6.4

248

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.4

1377

12438

S87

ICPC

Dermatitis/atopic eczema

2.2

6.4

235

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

6.4

329

160

Kela drug reimbursment

exenatide

2.9

6.4

102

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.7

6.4

Z03

ICPC

Housing/neighbourhood problem

4.1

6.3

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

6.6

6.3

DHA10

NOMESCO Finland

Biopsy of cavity of nose

8.2

6.3

Y1202

ICD-8 Finland

Skin tests, Allergy tests

8.2

6.3

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.1

6.3

269

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.6

6.3

A07AA09

ATC

vancomycin; oral

3.6

6.3

D07AC14

ATC

methylprednisolone aceponate; topical

1.9

6.3

422

RF212, ,

NOMESCO Finland

6.0

6.3

M54.8

ICD-10 Finland

Other dorsalgia

1.9

6.3

408

A10BK03

ATC

empagliflozin; oral

1.6

6.3

149

965

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.0

6.3

324

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

6.3

249

1794

SPAT1259

SPAT

Opinion on plain films

3.3

6.3

S10

ICPC

Boil/carbuncle

1.7

6.3

102

600

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

6.3

304

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

6.2

DPA20

NOMESCO Finland

Trephine of frontal sinus

+∞

6.2

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

+∞

6.2

13597

ICD-8 Finland

Sarcoidosis, Suspecta

+∞

6.2

297, ,

Kela drug reimbursment

+∞

6.2

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

+∞

6.2

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

6.2

D86.3

ICD-10 Finland

Sarcoidosis of skin

+∞

6.2

GX1C5

NOMESCO Finland

PEF monitoring for assessment of efficacy of asthma management

+∞

6.2

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

6.2

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

6.2

J01GB01

ATC

tobramycin; inhalant, parenteral

+∞

6.2

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

6.2

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

6.2

R05DB20

ATC

other cough suppressants - combinations

1.8

6.2

563

M01AH03

ATC

valdecoxib; oral

1.8

6.2

563

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

6.2

133

840

L13

ICPC

Hip symptom/complaint

1.4

6.2

337

2560

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

6.2

346

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

6.2

121

747

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.9

6.2

417

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.9

6.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

6.2

B02.9

ICD-10 Finland

Zoster without complication

1.7

6.2

117

717

M43.0

ICD-10 Finland

Spondylolysis

2.7

6.2

115

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

6.2

454

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

6.2

454

T82

ICPC

Obesity

1.9

6.2

361

C10AC01

ATC

colestyramine; oral

2.2

6.2

219

H16.0

ICD-10 Finland

Corneal ulcer

1.8

6.2

491

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

2.9

6.2

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

6.1

204

1421

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

6.1

288

2137

S76.4

ICD-10 Finland

Injury of other and unspecified muscles and tendons at thigh level

3.2

6.1

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

6.1

226

K92.1

ICD-10 Finland

Melaena

1.8

6.1

477

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

6.1

419

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.5

6.1

139

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

2.8

6.1

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

3.8

6.1

UJF32, ,

SPAT

2.0

6.1

335

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

12.5

6.1

C02DE04, ,

ATC

2.2

6.1

227

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

6.1

435

SPAT1308

SPAT

Sexual health counselling

1.4

6.0

235

1687

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.0

6.0

315

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

6.0

214

1510

R01AD

ATC

Corticosteroids

3.6

6.0

RK110, ,

NOMESCO Finland

6.7

6.0

EC1VA, ,

NOMESCO Finland

1.8

6.0

539

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.5

6.0

140

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

6.0

140

M01AB01

ATC

indometacin; systemic, rectal

1.6

6.0

118

730

U02

ICPC

Urinary frequency/urgency

1.4

6.0

279

2067

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

396

663

6.92

232.63

1.5

1.1

267.16

171.17

u/ml

1.80

384

606

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

58.05

168.96

1.4

1.0

1.57

2.30

u/ml

—

(3023419) Bacteria identified in Sputum by Culture

40.34

134.69

3.5

1.0

—

(3025159) Blasts/Leukocytes in Blood

414

1320

3.56

107.31

5.0

4.3

0.03

0.44

0.78

275

(3021440) Promyelocytes/Leukocytes in Blood

401

1286

3.53

102.77

4.5

4.1

0.04

0.11

1.12

270

(3017181) Myelocytes/Leukocytes in Blood

408

1327

3.48

102.26

4.5

4.1

0.62

0.80

0.64

312

(3013115) Eosinophils [#/volume] in Blood

1403

8618

2.45

101.46

6.7

5.5

0.22

0.18

e9/l

11.22

1309

7394

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

121

132

9.58

101.04

3.3

2.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

145

215

7.10

93.77

1.2

1.0

2.31

1.25

u/ml

0.64

(3001604) Monocytes [#/volume] in Blood

1346

8356

2.34

91.62

6.4

5.2

0.61

0.55

e9/l

17.55

1245

7038

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

271

720

4.10

90.90

1.7

1.2

—

(3006315) Basophils [#/volume] in Blood

1347

8383

2.33

90.90

6.5

5.3

0.04

e9/l

4.90

1246

7059

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

52.03

88.61

4.3

2.6

—

(3042631) Mycobacterium sp identified in Specimen

18.24

88.10

3.7

2.1

—

(3018010) Neutrophils/Leukocytes in Blood

1268

7767

2.29

87.86

6.2

5.3

57.50

55.87

5.74

1240

7359

(3019198) Lymphocytes [#/volume] in Blood

1364

8650

2.28

86.44

6.4

5.3

1.96

1.95

e9/l

0.10

1284

7490

(3019069) Monocytes/Leukocytes in Blood

1248

7636

2.28

86.17

6.5

5.5

8.67

8.81

1.07

1209

7067

(3006504) Eosinophils/Leukocytes in Blood

1246

7620

2.28

86.12

6.4

5.4

3.14

2.82

3.95

1209

7038

(3002179) Metamyelocytes/Leukocytes in Blood

374

1278

3.27

85.77

4.1

3.9

0.49

0.72

0.76

307

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

12.97

85.66

1.9

1.3

—

(3022096) Basophils/Leukocytes in Blood

1246

7640

2.27

85.32

6.4

5.5

0.69

0.26

1205

7048

(3000492) Spirometry study

352

1182

3.30

82.94

1.6

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

445

1728

2.92

81.45

2.2

1.4

—

(3002030) Lymphocytes/Leukocytes in Blood

1265

7947

2.21

79.83

6.5

5.4

27.61

29.58

9.41

1233

7434

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

148

264

5.90

79.75

1.2

1.1

2.35

2.72

u/ml

0.13

119

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

22.89

76.73

1.1

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

743

3818

2.35

75.66

4.5

3.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

129

226

5.96

70.75

1.1

1.0

3.44

4.79

u/ml

0.53

103

(3014133) Dog dander IgE Ab [Units/volume] in Serum

120

198

6.32

69.92

1.2

1.0

5.34

3.06

u/ml

0.68

(3008401) Mugwort IgE Ab [Units/volume] in Serum

125

224

5.82

66.94

1.1

1.0

0.47

2.15

u/ml

1.07

(3023368) Bacteria identified in Blood by Culture

662

3458

2.25

63.12

4.5

3.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

743

4093

2.16

61.84

3.4

2.1

1156.18

656.62

ng/l

3.96

637

3424

(3013650) Neutrophils [#/volume] in Blood by Automated count

1406

9807

2.00

60.56

9.2

7.8

4.35

3.88

e9/l

13.18

1304

8339

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

101

171

6.11

57.30

1.1

1.0

0.26

0.23

u/ml

0.06

(3036481) Cortisol [Moles/volume] in Serum or Plasma

324

1327

2.66

52.18

2.4

2.1

325.57

389.34

nmol/l

7.63

305

1231

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

296

1163

2.75

51.71

2.2

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

307

1235

2.69

51.20

2.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

188

5.38

48.71

1.1

5.63

3.18

u/ml

0.77

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

938

6032

1.89

47.96

4.0

2.8

28.88

47.12

ng/l

1.65

643

3942

(3021589) Normoblasts [#/volume] in Blood

1162

8059

1.83

46.16

13.5

8.7

0.00

e9/l

1.50

1041

6578

(3027801) Oxygen [Partial pressure] in Arterial blood

314

1367

2.48

44.22

5.3

6.1

11.10

14.14

kpa

21.16

303

1320

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

314

1368

2.48

44.14

5.3

6.1

5.22

5.01

kpa

3.39

302

1320

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

12.08

43.71

1.2

1.1

11.95

17.44

u/ml

0.54

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

179

582

3.24

43.66

3.0

3.3

1.76

1.56

0.77

174

547

(3032080) INR in Blood by Coagulation assay

1073

7412

1.79

41.93

13.3

10.5

1.21

inr

0.13

943

6013

(3016502) Oxygen saturation in Arterial blood

284

1214

2.51

41.48

5.2

6.5

94.90

96.62

4.68

272

1173

(3019977) pH of Arterial blood

306

1374

2.40

40.09

5.4

6.1

7.42

7.41

1.02

198

700

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

813

5277

1.80

38.39

2.8

2.3

52.62

61.83

u/l

6.45

771

4846

(3003396) Base excess in Arterial blood by calculation

296

1358

2.34

36.80

5.5

6.1

1.81

0.26

mmol/l

10.32

251

1108

(3019060) Gas panel - Arterial blood

174

620

2.94

36.17

3.6

3.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1197

8776

1.70

36.04

6.2

5.3

10.61

12.20

umol/l

5.54

1153

8306

(3005719) IgG [Mass/volume] in Serum or Plasma

238

1007

2.51

35.35

2.7

2.3

9.94

11.03

g/l

3.94

230

913

(3017569) Oxygen content in Arterial blood

10.41

34.25

1.7

1.5

16.89

17.05

0.08

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

153

4.95

33.79

1.5

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

144

482

3.11

33.37

2.1

1.2

39.75

39.13

u/l

0.12

132

431

(42870588) Differential panel, method unspecified - Blood

779

5164

1.74

33.22

6.5

5.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

7.18

32.23

1.4

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

555

3362

1.84

31.97

2.0

1.5

0.93

1.24

mg/l

2.53

433

2521

(3013826) Glucose [Moles/volume] in Serum or Plasma

1343

10368

1.64

31.47

5.1

3.5

6.39

6.55

mmol/l

2.57

1286

9599

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1658

13566

1.67

30.31

5.3

3.6

12.62

10.38

mm/h

7.95

1603

12601

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

134

459

3.03

29.83

2.2

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

4.92

29.54

1.4

1.1

—

(3009343) pH of Capillary blood

180

725

2.60

29.52

3.7

2.8

7.41

0.19

163

592

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

116

371

3.23

29.01

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

145

533

2.83

28.42

3.2

3.4

0.76

0.89

3.70

138

498

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.75

28.20

1.4

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

10.83

27.78

4.7

2.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

177

729

2.54

27.71

4.5

5.3

25.45

23.99

mmol/l

4.31

172

694

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

158

620

2.65

27.30

1.8

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

187

797

2.46

27.21

1.7

1.8

1.31

1.39

g/l

0.25

179

723

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

171

4.24

26.89

1.5

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

249

3.63

26.65

1.9

1.1

10.21

10.63

mg/l

0.17

232

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

366

2055

1.92

26.29

2.9

2.2

23.27

24.19

0.51

344

1885

(3017732) Neutrophils [#/volume] in Blood

366

2058

1.91

26.16

3.4

3.1

4.72

4.67

e9/l

0.04

335

1785

(3041096) Erythrocytes [Presence] in Urine by Automated

771

5367

1.63

26.03

3.6

2.9

0.01

0.59

estimate

1.38

299

1531

(3022948) Iron [Moles/volume] in Serum or Plasma

424

2505

1.83

25.94

2.8

2.1

13.62

14.13

umol/l

0.42

401

2305

(3037522) Nuclear Ab [Titer] in Serum

376

2140

1.89

25.88

1.5

1.3

397.58

577.89

titre

1.47

427

(3024139) IgG subclass 3 [Mass/volume] in Serum

5.67

25.70

1.5

1.3

0.32

0.41

g/l

1.28

(3027135) IgG subclass 1 [Mass/volume] in Serum

5.67

25.70

1.5

1.3

6.10

7.30

g/l

1.23

(3028192) IgG subclass 2 [Mass/volume] in Serum

5.67

25.70

1.5

1.3

2.63

3.36

g/l

1.79

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1119

8528

1.57

25.65

7.6

5.1

1.22

mmol/l

0.54

1008

7309

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

124

4.76

25.49

1.4

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

497

3101

1.75

25.23

1.4

1.3

27.87

27.28

iu/ml

0.04

143

932

(3004789) Transferrin [Mass/volume] in Serum or Plasma

391

2274

1.85

25.10

2.8

2.1

2.45

2.34

g/l

3.50

372

2079

(4062490) Immunoglobulin typing, IgG

5.55

24.61

1.6

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

156

640

2.53

24.60

3.6

2.7

2.52

0.98

mmol/l

6.71

105

432

(3007853) Bacteria identified in Skin by Aerobe culture

314

1712

1.95

24.52

2.0

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

200

922

2.27

24.31

3.9

2.0

113.91

113.39

ng/l

0.01

180

826

(3044242) Glucose [Moles/volume] in Arterial blood

7.38

24.17

1.5

1.6

7.50

9.00

mmol/l

0.82

(3042936) Bacteria identified in Isolate by Culture

341

1924

1.89

24.00

2.2

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

118

426

2.86

23.91

2.2

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

269

1405

2.03

23.71

3.8

2.7

6.01

5.69

kpa

4.32

261

1369

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

295

3.24

23.59

2.2

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1655

13946

1.56

23.00

8.4

6.3

77.10

78.50

u/l

0.78

1608

13061

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

5.37

22.78

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

114

4.64

22.19

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

114

4.64

22.19

1.3

1.1

—

(3045424) Erythrocytes [Presence] in Urine

182

840

2.26

22.04

2.0

0.00

0.01

estimate

0.69

116

290

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

247

1293

2.01

21.58

3.7

3.1

1.23

mmol/l

0.15

232

1081

(3024561) Albumin [Mass/volume] in Serum or Plasma

1001

7650

1.52

21.42

5.1

4.0

35.66

36.47

g/l

4.77

951

7122

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

195

953

2.13

20.47

1.5

—

(3026782) Osmolality of Urine

480

3152

1.65

19.65

3.1

2.6

515.35

545.24

mosm/kgh2o

2.11

438

2701

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

5.90

19.62

1.6

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

6.03

19.49

1.7

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

708

5121

1.53

19.11

2.1

1.9

159.60

216.62

u/l

1.50

678

4829

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

351

2.80

19.04

1.7

1.6

0.91

3.61

ug/l

1.39

299

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

446

2899

1.66

18.94

3.9

2.8

130.20

577.22

ng/l

3.36

276

2099

(3000850) Epithelial cells [#/volume] in Urine

539

3696

1.59

18.33

2.6

2.4

5.45

5.89

e6/l

0.40

511

3297

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1082

8623

1.45

17.68

2.7

2.2

77.09

77.51

nmol/l

0.20

1032

7839

(3024354) Oxygen [Partial pressure] in Venous blood

225

1223

1.92

17.55

3.7

2.4

4.68

4.56

kpa

0.24

218

1192

(3008037) Lactate [Moles/volume] in Venous blood

388

2.62

17.18

2.2

2.1

1.41

1.65

mmol/l

2.39

374

(3026493) Urate [Moles/volume] in Serum or Plasma

592

4204

1.54

17.08

2.8

2.2

342.21

328.30

umol/l

2.83

553

3736

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

434

2869

1.62

17.08

1.4

1.3

7.34

11.33

u/ml

1.10

230

1192

(3030981) Hyaline casts [#/volume] in Urine by Automated count

246

1394

1.85

16.86

2.5

2.1

0.39

0.37

e6/l

0.06

237

1326

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

966

7592

1.45

16.72

4.0

3.3

0.01

0.41

estimate

0.68

289

1595

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

180

3.39

16.71

1.2

1.1

105.71

315.00

titre

—

(3029937) Albumin [Presence] in Urine by Test strip

735

5499

1.48

16.37

4.3

3.4

0.01

0.00

estimate

0.19

383

1831

(3007164) IgA [Mass/volume] in Serum or Plasma

527

3683

1.55

16.25

1.5

1.4

2.28

2.27

g/l

0.05

396

2231

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

627

4551

1.50

16.19

2.5

2.1

2.90

2.70

mg/l

1.44

570

3887

(3002582) Erythrocytes [#/volume] in Urine

741

5564

1.47

16.17

3.5

2.9

103.15

98.70

e6/l

0.03

607

4096

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

6.01

16.04

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

6.01

16.04

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

6.01

16.04

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

360

2.61

16.03

4.4

4.0

1.35

1.22

mmol/l

0.49

306

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

21.08

15.96

1.3

1.0

—

(1616796) Gas panel - Central venous blood

211

3.14

15.95

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

399

2.52

15.75

1.3

1.2

—

(44813793) Dust mix specific IgE antibody measurement

4.47

15.65

1.1

1.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

313

1944

1.70

15.61

5.6

5.4

103.94

104.81

mmol/l

2.59

313

1944

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1128

9205

1.41

15.46

3.4

2.8

108.73

104.24

ug/l

0.21

1078

8603

(3024980) IgG subclass 4 [Mass/volume] in Serum

190

3.21

15.35

1.5

0.64

0.84

g/l

1.04

148

(3002032) Base excess in Venous blood by calculation

236

1366

1.80

15.06

4.0

2.8

2.31

1.45

mmol/l

2.50

205

1160

(40768797) Stomach Pathology biopsy report

348

2246

1.64

14.95

1.2

—

(4015189) Microbial culture of sputum

31.88

14.80

2.7

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1195

9928

1.39

14.36

4.1

3.4

0.00

estimate

0.50

395

1974

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

757

5854

1.42

13.64

3.2

2.8

32.93

32.17

u/l

0.10

720

5524

(3012441) Differential panel - Pleural fluid

16.28

13.44

1.1

1.2

—

(3026008) Bacteria identified in Urine by Culture

712

5460

1.43

13.40

3.2

2.8

—

(3012544) pH of Venous blood

238

1431

1.73

13.30

4.0

2.8

7.38

0.13

160

792

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

6.33

13.28

1.5

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1207

10132

1.37

13.18

4.1

3.4

0.00

0.17

estimate

0.54

372

1935

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

329

2.51

13.13

1.2

1.1

4.79

5.06

0.09

(44806118) Parainfluenza type 4 nucleic acid detection

4.00

12.90

1.5

1.1

—

(44790049) Parainfluenza type 3 nucleic acid detection

4.00

12.90

1.5

1.1

—

(44790047) Parainfluenza type 1 nucleic acid detection

4.00

12.90

1.5

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

4.00

12.90

1.5

1.1

—

(3039000) Anion gap in Blood by calculation

239

2.76

12.84

4.3

4.8

11.17

11.24

mmol/l

0.06

209

(3000494) Fungus identified in Specimen by Culture

295

1895

1.63

12.83

1.5

1.3

—

(3018572) Chloride [Moles/volume] in Blood

240

2.75

12.74

4.3

4.8

103.62

105.86

mmol/l

3.46

210

(40768806) Pleura Pathology biopsy report

13.22

12.42

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

4.04

12.37

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

5.14

12.20

1.0

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

343

2317

1.56

12.04

3.3

2.7

0.82

0.83

mmol/l

0.16

322

2175

(3026389) Candida sp identified in Specimen by Organism specific culture

226

2.74

11.90

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1383

11975

1.35

11.81

3.6

2.9

—

(3035350) Ketones [Presence] in Urine by Test strip

1191

10084

1.35

11.80

4.1

3.4

0.00

3.78

estimate

1.58

405

2031

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.20

11.52

1.9

2.3

—

(3018095) Leukocytes [#/volume] in Urine

829

6665

1.37

11.40

4.1

3.3

119.55

106.37

e6/l

0.13

649

4370

(3012494) Peanut IgE Ab [Units/volume] in Serum

5.40

11.34

1.1

1.59

6.92

u/ml

0.52

(3014111) Lactate [Moles/volume] in Serum or Plasma

197

1177

1.73

11.25

7.1

5.8

1.40

1.35

mmol/l

0.25

191

1157

(3045414) Leukocytes [Presence] in Urine

268

1736

1.61

11.23

2.1

1.9

0.00

0.01

estimate

0.78

124

370

(3022145) Colonoscopy Study observation

290

1922

1.58

11.03

1.3

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

9.23

10.99

1.5

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1680

15072

1.35

10.85

4.5

4.1

14.80

14.64

pmol/l

1.80

1582

13762

(3022313) Gas panel - Capillary blood

108

541

2.04

10.68

3.9

2.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

14.25

10.47

1.2

40696.67

11666.29

e6/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

3.62

10.35

1.1

1.0

4.72

13.19

iu/ml

1.36

(3027456) Digoxin [Moles/volume] in Serum or Plasma

153

2.98

10.31

3.3

2.7

0.76

0.72

nmol/l

0.36

113

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

3.68

9.97

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

501

3780

1.41

9.92

1.8

1.6

58503840.88

33005825.90

pmol/l

0.38

441

3151

(3003458) Phosphate [Moles/volume] in Serum or Plasma

280

1886

1.55

9.89

6.3

4.2

1.09

1.03

mmol/l

2.48

259

1731

(3031040) Bacteria [#/volume] in Urine by Automated count

1399

12311

1.31

9.79

4.9

4.0

703.87

2099.69

e6/l

1.13

159

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

9.56

9.75

1.6

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

9.56

9.75

1.6

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

764

6192

1.34

9.60

3.1

2.9

2.35

2.36

mmol/l

0.87

709

5618

(3015171) Extractable nuclear Ab [Units/volume] in Serum

107

556

1.97

9.58

1.4

1.2

0.19

0.69

u/ml

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2044

19061

1.41

9.42

19.5

10.0

20.01

22.14

mg/l

2.68

1824

14561

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

+∞

9.38

1.4

0.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

175

1065

1.69

9.36

1.9

2.1

67.00

67.43

g/l

0.36

160

946

(3018418) pH of Serum or Plasma

625

4931

1.36

9.35

4.7

3.3

7.40

0.15

483

3411

(3011985) Renin [Units/volume] in Plasma

208

2.58

9.31

1.6

1.4

28.96

55.02

mu/l

0.88

184

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

247

2.42

9.06

1.2

1.1

8.12

14.77

au/ml

0.75

(3034891) Synovial lining cells/cells in Synovial fluid

4.00

9.05

1.6

1.5

—

0.82

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

369

2.15

9.01

1.3

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

10.72

8.78

1.6

1.1

16.00

14.33

u/l

0.23

(3048689) Calprotectin [Mass/mass] in Stool

338

2425

1.46

8.76

2.6

2.4

117.85

123.52

ug/g

0.14

268

1911

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

323

2.20

8.61

3.6

2.4

9.67

8.46

pmol/l

0.38

323

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

225

1490

1.56

8.56

2.4

2.2

0.21

0.22

g/l

0.59

214

1391

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

6.94

8.53

1.1

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

6.94

8.53

1.1

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

6.94

8.53

1.1

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

6.94

8.53

1.1

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

597

4744

1.34

8.39

3.3

2.8

0.57

0.35

e6/l

1.24

475

3357

(3020779) Urea [Moles/volume] in Serum or Plasma

182

1153

1.62

8.35

7.4

4.9

10.09

8.78

mmol/l

1.62

175

1101

(3047007) Chlamydophila sp Ab [Presence] in Serum

180

2.58

8.17

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

11.72

8.07

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

340

2.12

7.99

1.6

—

(3012501) Base excess in Blood by calculation

214

2.41

7.84

4.6

2.1

2.42

2.16

mmol/l

0.28

116

(3048929) Epstein Barr virus Ab [Presence] in Serum

489

1.91

7.77

1.3

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

117

2.93

7.70

1.6

1.5

31.81

28.07

0.17

(3035637) Corticotropin [Mass/volume] in Plasma

162

2.62

7.69

1.5

1.7

23.08

30.84

ng/l

0.40

162

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.92

7.67

1.2

1.5

1.20

1.17

mmol/l

1.38

(21494815) CD4 cells/Lymphocytes in Specimen

3.45

7.66

1.4

2.5

41.08

40.99

0.01

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

230

2.33

7.57

5.6

3.7

139.50

319.61

iu/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

316

2.12

7.45

3.5

2.8

0.35

0.36

iu/ml

0.16

159

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

880

7495

1.27

7.14

6.9

4.7

1.21

1.22

mmol/l

1.56

827

6845

(3015076) Soybean IgE Ab [Units/volume] in Serum

3.20

7.11

1.0

0.68

5.79

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

158

2.56

7.01

1.2

1.1

2.98

5.26

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

4.21

7.00

1.3

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

561

4523

1.31

6.96

1.3

1.49

1.91

u/ml

0.49

202

1213

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1416

12783

1.25

6.80

3.3

2.8

46.06

41.10

u/l

1.76

1360

12051

(3004588) Protein electrophoresis panel - Serum or Plasma

145

920

1.61

6.66

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

3.00

6.65

1.0

1.1

0.55

0.38

u/ml

0.28

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

418

1.89

6.48

2.1

2.3

27.75

41.17

mg/l

1.34

362

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.66

6.47

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

281

2.09

6.40

1.6

1.9

135.22

131.04

g/l

0.55

229

(3034860) Kappa light chains.free [Mass/volume] in Serum

420

1.88

6.39

2.1

2.3

52.59

43.73

mg/l

0.30

359

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

447

3532

1.32

6.36

3.1

2.7

2.46

2.44

mmol/l

1.58

404

3157

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

469

1.82

6.16

1.5

0.16

0.17

iu/ml

0.01

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.34

6.14

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.34

6.14

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

5.34

6.14

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.34

6.14

1.1

—

(3025941) Bacteria identified in Stool by Culture

137

895

1.56

5.60

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.81

5.56

1.0

1.1

1.12

0.45

u/ml

0.57

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

361

1.88

5.53

2.0

2.1

2.42

3.06

ratio

0.21

203

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

155

1048

1.51

5.43

3.1

3.4

4.41

4.57

pmol/l

1.58

148

930

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

440

1.77

5.28

3.5

3.4

1.53

1.33

mg/l

1.35

400

(3019550) Sodium [Moles/volume] in Serum or Plasma

2036

19394

1.28

5.08

20.3

12.4

139.48

139.81

mmol/l

6.84

2013

18872

(3023103) Potassium [Moles/volume] in Serum or Plasma

2040

19442

1.28

5.03

20.5

12.5

3.97

3.96

mmol/l

0.33

2019

18876

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

166

1157

1.47

5.03

4.0

3.2

87.49

76.46

ng/l

0.83

141

1012

(3018677) aPTT in Platelet poor plasma by Coagulation assay

298

2302

1.33

4.92

2.2

1.8

29.10

29.20

0.13

292

2240

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.35

4.88

4.0

1.6

524.82

1252.04

u/ml

0.89

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.79

4.87

1.1

1.12

9.83

nmol/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

106

677

1.59

4.82

2.2

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

576

1.64

4.79

1.8

1.6

6.50

7.85

iu/ml

0.11

129

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1929

18295

1.24

4.77

17.9

10.8

83.66

82.99

ml/min/173m2

0.68

1813

16592

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.65

4.73

2.0

1.6

4.34

4.25

g/l

0.62

486

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.65

4.73

2.0

1.6

3.55

3.71

g/l

0.53

487

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.65

4.73

2.0

1.6

7.26

g/l

0.00

486

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

427

3490

1.27

4.61

1.8

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

467

1.69

4.58

2.2

1.7

0.84

0.95

g/l

0.08

393

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

452

1.70

4.58

2.0

1.9

778.45

1187.68

ug/l

0.22

429

(3008536) Aspergillus sp Ab [Presence] in Serum

14.03

4.57

1.3

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

175

2.13

4.44

1.4

1.3

—

nmol/l

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.83

4.38

1.5

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.57

4.38

1.9

2.0

3.75

2.91

u/field

0.11

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

512

1.64

4.37

2.1

1.6

2.63

2.83

g/l

1.21

452

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

155

2147

0.70

4.34

6.4

5.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

242

1849

1.34

4.32

2.8

2.4

7.95

8.83

umol/l

0.26

211

1615

(3023323) Follitropin [Units/volume] in Serum or Plasma

146

1025

1.45

4.30

1.5

1.4

22.40

26.69

iu/l

0.98

129

862

(3011897) Casein IgE Ab [Units/volume] in Serum

5.52

4.28

1.1

1.2

0.59

0.48

u/ml

0.07

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

386

1.73

4.24

2.3

1.6

0.02

0.01

g/l

0.21

343

(3021960) Folate [Moles/volume] in Serum or Plasma

600

5145

1.22

4.16

1.6

19.79

20.81

nmol/l

0.88

537

4328

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

382

1.72

4.12

1.5

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

154

2.16

4.11

1.8

1.7

67.73

61.39

0.43

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

162

1170

1.41

4.10

2.0

2.1

3.99

7.20

ug/l

4.49

146

1022

(3004809) Band form neutrophils/Leukocytes in Blood

192

1.99

3.87

3.8

3.5

3.15

1.27

0.81

172

(3003181) Sodium [Moles/volume] in Urine

227

1.91

3.87

1.5

1.4

63.06

66.11

mmol/l

0.20

188

(3000991) Gas panel - Venous blood

160

1167

1.40

3.84

7.7

6.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

187

1.99

3.78

1.2

1.3

0.18

nmol/l

0.25

146

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

12.02

3.76

1.0

0.00

0.16

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

295

1.78

3.75

1.6

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.15

3.70

2.2

1.8

5.58

4.55

kpa

2.76

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.15

3.70

2.2

1.8

9.03

10.57

kpa

1.13

(3024932) HLA-DR beta [Type]

5.01

3.68

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

272

2167

1.29

3.61

1.5

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.36

3.57

1.1

1.3

65.39

79.36

umol/l

3.12

(3038515) Glucose [Moles/volume] in Venous blood

330

1.71

3.56

2.2

7.02

7.63

mmol/l

1.27

319

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

272

2174

1.28

3.52

1.7

1.49

1.39

1.79

242

1945

(3034274) Bile acid [Moles/volume] in Serum --fasting

294

1.75

3.50

1.8

2.3

5.10

8.33

umol/l

0.80

214

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

6.17

3.50

1.6

1.0

90.88

95.31

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.62

3.49

2.2

3.2

0.64

0.61

mmol/l

0.68

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

188

2431

0.75

3.42

1.7

1.9

3.63

3.40

ratio

1.37

134

1831

(3024891) Influenza virus A+B Ag [Presence] in Specimen

327

1.70

3.40

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.76

3.38

1.0

21.60

52.49

iu/ml

1.40

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

902

8144

1.17

3.38

2.0

95.87

97.26

pmol/l

0.41

504

4204

(1002224) Polysomnography panel

111

778

1.45

3.36

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1719

16312

1.17

3.35

23.2

13.5

13.78

13.42

25.04

1706

16025

(40768804) Tissue Pathology biopsy report

835

7498

1.17

3.34

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

716

0.57

3.34

1.2

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

383

1.63

3.33

1.3

1.4

317.08

10890.76

e6/l

0.55

300

(3002079) Sodium [Moles/time] in 24 hour Urine

2.72

3.32

1.4

1.3

191.84

154.89

mmol/24h

0.96

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.42

3.30

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.93

3.29

1.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

610

5343

1.19

3.29

2.7

0.00

0.05

—

147

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

975

8879

1.16

3.23

2.8

2.5

—

estimate

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

627

1.48

3.22

1.7

11.86

16.63

u/ml

0.62

169

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

325

2682

1.24

3.22

3.4

2.6

4.44

2.73

e6/l

1.31

189

1288

(3003327) Ova and parasites identified in Stool by Light microscopy

619

1.49

3.22

1.4

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

3.54

3.19

1.9

1.8

0.44

0.26

e9/l

—

(3042733) HLA Ab [Presence] in Serum

4.18

3.19

4.8

4.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.36

3.15

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

172

1.93

3.14

1.0

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1597

16793

0.86

3.12

21.7

14.3

331.77

332.72

g/l

3.97

1584

16671

(3009508) Creatinine [Moles/volume] in Urine

710

6324

1.17

3.11

3.2

3.3

7.58

7.61

mmol/l

0.06

638

5380

(3024471) HLA-A [Type]

4.51

3.11

1.0

—

(3005570) Glucose [Moles/volume] in Urine

194

1.87

3.11

2.5

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

458

3929

1.20

3.10

2.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

166

1.94

3.09

3.4

4.2

17.25

47.67

u/ml

1.42

166

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

170

2196

0.76

3.08

4.8

4.7

32.35

32.70

0.16

117

1428

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

368

1.62

3.07

1.2

3.62

3.63

mmol/l

0.03

347

(3030313) Adrenal Ab [Titer] in Serum

7.51

3.05

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

166

1269

1.33

3.02

2.2

2.4

73.93

66.10

e9/l

1.95

132

916

(3052592) Norovirus Ag [Presence] in Stool

5.84

3.02

2.3

1.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

212

1679

1.29

2.98

2.5

2.4

1.84

1.69

1.27

192

1481

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

10.01

2.98

1.0

1.2

0.49

0.12

u/ml

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1882

18051

1.18

2.97

5.6

4.9

1.90

mu/l

0.05

1785

16672

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

127

2.06

2.96

1.2

1.1

103.19

124.00

pmol/l

0.63

127

(3027944) Amphetamines [Presence] in Urine

126

926

1.38

2.96

1.9

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

127

935

1.38

2.95

1.9

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

468

1.53

2.94

2.2

1.6

10.27

10.40

g/l

0.09

404

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

428

1.56

2.94

1.3

2.47

6.25

u/ml

—

(21494814) CD8 cells/Lymphocytes in Specimen

3.25

2.93

1.6

2.7

27.25

27.43

0.02

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

216

1720

1.28

2.91

3.6

4.0

5.00

45.49

ug/l

1.33

190

1371

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.59

2.87

1.9

2.2

8.83

9.10

mg/l

0.06

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

346

1.60

2.80

1.3

1.2

12.37

2.06

u/ml

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

370

1.58

2.78

2.4

1.7

0.00

g/l

-0.00

324

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.09

2.77

1.0

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

451

1.52

2.76

1.1

1.2

51.43

91.30

titre

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

427

1.54

2.75

1.3

7.60

2.75

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

138

1.97

2.75

4.1

3.3

7.77

6.81

mmol/l

0.29

114

(3006922) Hepatitis E virus Ab [Presence] in Serum

111

2.08

2.72

1.0

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

601

1.45

2.71

1.6

1.7

1.52

1.45

g/l

0.30

514

(3022689) Creatine [Moles/volume] in Urine

2.51

2.70

1.2

1.3

6.55

9.44

mmol/l

1.03

(3035715) Granulocytes [#/volume] in Blood

204

1.78

2.69

3.0

3.7

4.03

3.52

e9/l

1.22

204

(3017446) Testosterone [Moles/volume] in Serum or Plasma

181

1428

1.29

2.65

2.6

2.2

11.68

12.38

nmol/l

0.59

158

1289

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.34

2.60

1.0

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

257

2123

1.23

2.55

1.6

1.5

—

(3028300) Cannabinoids [Presence] in Urine

125

943

1.34

2.53

1.9

2.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

277

1.64

2.52

1.7

1.3

169.93

148.95

au/ml

0.66

(3037756) Immunofixation for Serum or Plasma

254

1.66

2.52

1.3

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

255

1.66

2.48

1.3

18.74

22.86

u/l

0.48

214

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

431

1.50

2.45

1.3

513.50

528.95

mg/l

0.08

408

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

249

1.66

2.43

1.7

1.6

—

(3027008) Opiates [Presence] in Urine

124

941

1.33

2.42

1.9

1.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

465

1.47

2.42

1.5

1.4

292.84

284.46

ug/g

0.12

252

(3019309) Folate [Moles/volume] in Red Blood Cells

328

2794

1.20

2.41

1.6

1.7

1225.95

1137.09

nmol/l

0.96

259

2120

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

378

1.52

2.36

1.2

1.4

18.89

18.87

e6/l

0.00

276

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.13

2.36

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

568

1.42

2.35

1.6

1.4

9.44

8.94

u/l

0.13

449

(21494755) Public health laboratory ask at order entry panel

241

2000

1.23

2.31

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.76

2.27

1.0

0.22

3.34

u/ml

0.71

(3020682) Albumin/Creatinine [Ratio] in Urine

644

5815

1.14

2.27

3.7

4.0

8.54

6.26

mg/mmol

0.61

434

3490

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

653

0.64

2.25

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

352

1.52

2.20

2.1

2.3

117.82

72.32

ug/min

0.42

201

(4281824) Cell count and differential, peritoneal fluid

213

0.42

2.18

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.51

2.18

1.3

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

226

1.65

2.17

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.25

2.17

1.2

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.25

2.17

2.4

2.1

83.00

103.52

2.10

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

145

1820

0.78

2.16

1.6

1.7

3.49

3.44

mmol/l

0.15

1231

(3023511) Choriogonadotropin [Units/volume] in Urine

427

1.46

2.16

1.6

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

436

1.46

2.15

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1856

17933

1.14

2.08

6.2

5.6

39.12

38.30

mmol/mol

4.49

1788

16762

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

293

2505

1.19

2.08

2.2

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.01

2.07

1.6

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

149

1190

1.27

2.04

2.2

2.4

32.79

20.31

au/ml

0.52

150

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.01

2.04

1.5

1.3

—

(3016879) Cocaine [Presence] in Urine

112

862

1.31

2.03

1.8

2.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

738

8012

0.89

2.01

1.8

1.43

1.30

mmol/l

3.45

647

6810

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

319

1.51

2.01

1.3

1.2

—

101.22

—

(3000012) Reticulocyte production index

201

1.65

1.98

1.2

1.8

0.98

0.86

0.28

129

(3016650) Hepatitis A virus Ab [Presence] in Serum

240

1.59

1.98

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

126

1.83

1.98

1.3

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

296

1.53

1.98

1.3

1.2

229.17

242.53

u/ml

0.17

179

(3020961) Endomysium IgA Ab [Titer] in Serum

123

965

1.29

1.95

1.1

147.14

119.26

titre

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

180

1.67

1.91

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

2.25

1.90

2.5

2.6

42.25

39.88

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

1.89

1.90

1.2

1.1

30.01

18.45

u/ml

—

(3019150) Specific gravity of Urine by Refractometry

507

4556

1.14

1.90

3.9

3.5

1.02

1.71

kg/l

0.80

352

2927

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

158

1.72

1.88

1.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

654

1.34

1.88

2.5

2.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.19

1.88

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

850

7889

1.12

1.87

2.7

2.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

151

1.73

1.86

1.8

2.0

1.08

1.25

u/field

0.11

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

144

1.74

1.85

1.3

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

167

1369

1.24

1.84

1.3

1.2

135.96

132.96

u/ml

0.03

525

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

502

1.38

1.83

2.0

2.2

2.16

4.07

iu/l

2.83

226

(40757373) Influenza virus identified in Isolate

4.17

1.82

1.6

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

369

1.45

1.80

1.9

1.8

199.81

196.61

pmol/l

0.09

347

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.05

1.80

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

314

2741

1.17

1.76

2.2

—

(44806420) Estimation of glomerular filtration rate

232

0.47

1.76

2.3

2.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

297

1.49

1.75

1.3

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.34

1.74

1.3

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.34

1.74

1.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.34

1.74

1.3

1.5

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.67

1.72

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.92

1.72

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.85

1.71

40.8

9.6

5.16

6.00

mmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

529

0.66

1.71

1.6

1.5

61.27

59.72

ug/l

0.08

529

(3012516) Albumin [Mass/volume] in Urine

626

5737

1.12

1.71

3.2

3.3

65.04

35.66

mg/l

1.12

415

3483

(3035933) Granulocytes/Leukocytes in Blood

284

1.49

1.67

2.9

3.3

58.56

57.55

0.25

284

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

188

1.60

1.66

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

260

1.51

1.65

1.1

2.22

3.29

eliau/ml

0.29

121

(3021387) Prolactin [Units/volume] in Serum or Plasma

774

1.29

1.65

1.7

291.24

294.18

mu/l

0.04

710

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.80

1.65

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

169

1407

1.22

1.64

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

362

1.42

1.59

1.1

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.95

1.59

2.9

2.1

0.89

1.51

u/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.00

1.59

1.3

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.98

1.53

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

138

1.67

1.51

1.3

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.60

1.51

1.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

185

1.57

1.51

1.3

1.2

—

(40768443) Skin Pathology biopsy report

785

1.27

1.50

1.2

1.3

—

(3008898) HLA-B27 [Presence]

617

1.31

1.50

1.0

1.1

—

(3015736) pH of Urine

846

7927

1.10

1.50

3.4

3.0

6.18

6.25

0.96

515

4403

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.45

1.0

—

(40768441) Liver Pathology biopsy report

140

1.65

1.44

1.2

1.3

—

(40758558) Short blood count panel - Blood

580

5341

1.11

1.44

7.7

5.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.13

1.44

1.0

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

261

1.46

1.43

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.18

1.39

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.42

1.39

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.00

1.38

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.00

1.38

1.5

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.94

1.36

1.4

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.50

1.30

1.2

1.7

15.67

29.50

pmol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

343

1.38

1.30

2.8

—

(3049717) Cytology report of Urine Cyto stain

632

1.27

1.29

3.6

2.6

—

(3024263) Appearance of Synovial fluid

1.89

1.28

1.8

1.9

—

(3036489) Thrombin time

562

1.29

1.28

3.0

1.8

22.58

20.62

0.59

490

(3000475) Leukocytes [#/volume] in Synovial fluid

371

1.35

1.26

1.6

7159.64

13340.06

e6/l

1.03

256

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

158

1346

1.19

1.25

3.0

2.3

68.17

69.54

ml/min/173m2

0.17

540

(3006270) Folate [Moles/volume] in Blood

159

0.50

1.24

1.1

1.2

396.75

347.20

nmol/l

—

142

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.40

1.24

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.40

1.24

1.5

1.2

5.87

5.77

mmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

1.63

1.24

1.1

1.0

—

(4035726) Immunohistochemistry procedure

165

1413

1.18

1.24

1.2

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

187

1.50

1.23

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

116

1.64

1.21

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

729

1.24

1.20

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1884

18414

1.09

1.16

4.9

4.7

5.86

5.81

mmol/l

1.10

1787

16891

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2106

20697

1.11

1.16

22.5

14.1

77.27

74.52

umol/l

3.20

2091

20388

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

778

1.23

1.15

5.0

2.2

1.44

1.19

0.96

769

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.73

1.15

1.4

1.7

0.81

1.21

nmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

353

1.34

1.12

1.4

2.0

0.90

0.76

nmol/l

0.87

303

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

112

1332

0.83

1.11

1.5

1.6

1113.84

987.71

mu/l

0.71

1142

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

486

1.28

1.10

1.1

1.54

5.82

eliau/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.67

1.10

1.1

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

109

911

1.21

1.09

2.3

2.1

5386.41

6062.44

u/l

0.09

368

(44806071) Cardiolipin IgM antibody measurement

2.38

1.09

1.2

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.82

1.08

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

444

1.29

1.06

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

253

1.39

1.06

1.2

1.3

5.23

3.20

u/ml

0.23

(21494890) Protein electrophoresis panel - 24 hour Urine

105

1.62

1.06

1.5

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

113

1.60

1.05

1.3

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

129

1.55

1.05

1.3

1.0

299.40

249.51

mg/l

0.34

110

(40759836) Histone Ab [Presence] in Serum by Immunoblot

121

1.57

1.05

1.3

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

190

1673

1.15

1.03

2.0

2.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

485

0.74

1.03

1.5

1.4

64.35

136.53

pmol/l

1.45

475

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

122

1.56

1.02

1.9

1.4

20.00

19.48

u/ml

—

(3014271) Vancomycin [Susceptibility]

1.89

1.01

2.7

2.5

—

(3000330) Specific gravity of Urine by Test strip

110

929

1.19

1.01

3.4

3.1

1.02

ratio

0.99

831

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

239

1.39

1.00

1.2

1.3

2.92

3.02

u/ml

0.04

109

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.88

1.00

8.9

3.2

1.06

1.22

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.00

1.00

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

440

1.28

0.99

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

449

1.28

0.99

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

133

0.52

0.98

1.0

1.4

—

1022.77

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.18

0.98

1.2

1.0

—

(3044007) Cell count panel - Peritoneal fluid

1.95

0.97

1.1

1.7

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.80

0.96

1.1

89.16

42.64

u/ml

—

(3004451) EKG impression Narrative

1.85

0.96

1.5

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

108

1.58

0.96

1.2

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.74

0.96

1.1

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.74

0.96

1.1

1.0

131.92

215.18

iu/ml

0.98

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

175

1542

1.14

0.95

2.6

2.2

30.79

75.05

u/l

0.79

147

1286

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

602

0.78

0.95

1.6

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

285

1.34

0.94

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

117

1.54

0.93

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

117

1.54

0.93

1.3

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

850

0.82

0.90

1.5

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

111

1.53

0.87

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

104

1.54

0.84

1.3

170.13

265.72

pmol/l

0.52

104

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

137

1.46

0.84

1.5

1.1

55.22

40.75

mg/l

0.24

114

(3003694) ABO and Rh group [Type] in Blood

576

6089

0.93

0.83

1.6

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

129

1.48

0.83

1.1

—

(3002256) Pathology report gross observation

233

2562

0.90

0.82

1.3

—

(3005033) Fetal Nuchal fold Thickness US

566

0.79

0.82

1.4

1.5

1.27

0.02

411

(3045142) Bone marrow Pathology biopsy report

163

1.41

0.82

1.2

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.55

0.81

1.1

1.0

1.07

1.17

u/l

—

(4268621) Lupus anticoagulant assay

164

1.41

0.79

2.0

2.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.73

0.79

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

120

1047

1.15

0.79

1.7

—

(4034850) Laboratory test

565

1.21

0.78

6.3

9.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.62

0.78

1.4

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

182

1.38

0.77

1.4

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1.47

0.77

1.3

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

625

5936

1.07

0.77

2.6

2.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

140

1.43

0.76

2.1

1.5

30.90

34.74

nmol/l

0.34

124

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.52

0.75

2.2

2.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.60

0.74

1.5

1.95

umol/l

0.01

(3013139) Helicobacter pylori Ag [Presence] in Stool

145

1288

1.13

0.74

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

114

996

1.15

0.74

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

133

1.43

0.73

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

301

1.27

0.69

1.0

1.1

1.73

2042.93

iu/ml

0.51

(40758292) HTLV I+II Ab panel - Serum

1.85

0.68

1.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

584

0.82

0.68

1.4

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

358

3351

1.08

0.67

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.63

0.66

1.9

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

182

1653

1.11

0.66

3.4

2.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.61

0.65

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

163

1.35

0.64

1.0

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

130

0.61

0.63

1.0

461.50

354.35

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

131

0.61

0.63

1.0

59.59

46.97

ng/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

470

4454

1.07

0.63

2.5

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

777

1.15

0.62

5.1

2.2

0.59

0.63

0.64

771

(3042111) Morphology [Interpretation] in Bone marrow Narrative

208

1.30

0.62

2.6

1.6

—

(3051651) Icteric interference index of Serum or Plasma

1.59

0.61

3.4

3.7

0.70

1.03

index

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

673

0.84

0.61

1.4

—

(21494434) Karyotype in Bone marrow

130

1.39

0.61

1.6

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

750

1.15

0.61

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

356

0.78

0.60

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.50

0.59

1.1

1.2

9.17

8.67

mm/h

0.07

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1822

17945

1.06

0.59

4.1

3.9

1.32

1.23

mmol/l

5.27

1732

16581

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.72

0.57

1.2

1.1

—

8.06

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

785

0.86

0.56

1.1

1.55

1.54

g/l

0.12

785

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.67

0.56

1.5

2.1

18.37

17.91

umol/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

466

1.18

0.56

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.57

0.56

1.4

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

155

1412

1.10

0.56

1.9

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.62

0.55

1.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

107

1.40

0.55

4.9

3.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

148

0.67

0.55

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2078

20558

1.06

0.54

12.4

9.4

28.27

25.06

u/l

2.37

2045

19831

(40768795) Lymph node Pathology biopsy report

159

0.69

0.54

1.5

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.48

0.53

1.6

2.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

1.54

0.53

1.8

1.1

54.50

61.20

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

575

0.85

0.51

1.4

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

180

0.72

0.51

3.0

1.9

34.14

24.26

mg/l

—

(3037121) Protein [Mass/volume] in Urine

565

1.15

0.51

3.9

2.7

217.08

263.50

mg/l

0.41

226

(3034426) Prothrombin time (PT)

1.56

0.49

1.4

1.2

26.43

28.42

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.52

0.48

1.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.52

0.48

2.0

1.3

7.45

9.02

ug/l

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.52

0.48

1.0

1.2

—

(4195642) Thrombophilia screening test

235

1.24

0.48

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

267

2513

1.07

0.47

1.7

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.47

0.47

1.5

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.46

0.46

1.0

1.9

42.29

116.13

nmol/24h

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

712

1.13

0.46

1.6

0.28

0.31

mg/l

0.27

303

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

458

1.16

0.46

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.43

0.45

1.5

29.36

29.74

umol/l

0.05

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.40

0.45

1.0

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

256

1.21

0.44

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

321

1.19

0.43

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

321

1.19

0.43

1.2

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

193

1.25

0.43

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

1.38

0.42

1.0

1.1

152.32

130.98

nmol/l

0.97

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

258

1.20

0.41

2.4

2.5

20.18

1479.73

u/ml

0.74

258

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.52

0.41

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.41

0.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.43

0.39

5.6

6.4

8.00

8.35

mmol/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

179

1.23

0.37

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

430

1.14

0.37

3.5

3.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.35

0.37

5.0

2.5

4.20

285.38

ug/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

116

1.29

0.37

1.3

3.8

—

(4146454) Self-monitoring of blood glucose

191

0.78

0.36

2.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

682

0.89

0.36

1.4

1.5

0.88

0.96

ratio

0.68

398

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

682

0.89

0.36

1.4

1.5

1.17

1.24

ratio

0.18

402

(40761536) Microorganisms panel - Urine sediment

133

1430

0.93

0.36

4.8

3.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.27

0.36

1.8

2.0

—

158.20

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

681

0.89

0.36

1.4

1.5

1.17

1.19

ratio

0.05

397

(3005988) Vibrio sp identified in Specimen by Organism specific culture

180

1.22

0.35

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

180

1.22

0.35

1.2

—

(4133840) Spirometry

1.43

0.35

1.2

—

(3023410) Appearance of Cerebral spinal fluid

172

1.22

0.34

1.4

1.6

—

(40768446) Kidney Pathology biopsy report

1.33

0.33

1.3

1.5

—

(3025130) Human papilloma virus identified in Specimen

338

0.86

0.32

1.8

—

(40768793) Breast Pathology biopsy report

465

0.88

0.32

1.3

1.4

—

(36660697) Celiac disease serology panel - Serum

166

1565

1.06

0.31

1.1

1.2

—

(3022621) pH of Urine by Test strip

161

1517

1.07

0.31

2.7

2.5

6.00

6.09

0.72

116

1000

(3047189) Immunofixation for 24 hour Urine

1.35

0.31

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

269

1.15

0.29

1.1

—

(3044927) Protein electrophoresis panel - Urine

139

1.22

0.29

1.1

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

121

1.24

0.28

1.3

1.2

—

66.80

—

(3019225) pH of Specimen

172

1632

1.06

0.28

3.4

7.38

7.35

4.22

132

1117

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.29

0.28

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.25

0.27

1.3

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.25

0.27

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

122

1.23

0.27

1.1

1.2

—

(3017704) Immunofixation for Urine

1.19

0.26

1.1

1.5

—

(3020650) Glucose [Presence] in Urine

1.25

0.25

1.6

1.8

0.00

0.04

estimate

—

(4198724) Urine methamphetamine measurement

1.23

0.25

5.3

4.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

302

3122

0.96

0.24

3.1

3.3

0.75

0.85

ug/l

1.07

185

2033

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.25

0.24

1.0

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

336

3464

0.96

0.24

1.5

—

(3048879) Bone marrow aspiration report

1.32

0.23

1.0

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

106

1.23

0.23

1.1

1419.31

1495.02

miu/ml

0.11

106

(3036603) Volume of Urine

1.24

0.22

1.3

1.4

1945.67

1866.95

0.11

(40765096) Chromosome analysis panel by Banding

1.25

0.22

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

583

1.08

0.22

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.21

0.0

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.21

0.0

2.2

—

2157.40

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.1

—

1.35

—

(3019174) dRVVT (LA screen)

0.00

0.21

0.0

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

105

0.76

0.21

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.19

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

385

0.91

0.19

4.5

2.9

26.53

28.31

mg/l

0.11

256

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

300

0.90

0.18

1.3

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

383

0.91

0.18

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

620

0.93

0.17

2.7

3.3

44.98

862.06

u/ml

1.63

531

(3052851) Hemolysis interference index of Serum or Plasma

402

0.92

0.16

3.2

2.8

3.32

1.75

index

0.54

185

(3029396) Erythrocyte agglutination [Presence] in Blood

1.18

0.16

3.1

3.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

1.15

0.16

1.5

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

187

1.12

0.15

1.2

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.77

0.15

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

140

1.14

0.15

2.9

3.1

14.30

11.94

index

—

(3000963) Hemoglobin [Mass/volume] in Blood

2154

21600

0.98

0.14

27.3

17.1

135.39

135.51

g/l

0.15

2143

21312

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

299

2925

1.02

0.14

3.3

2.6

2.30

1.33

e6/l

0.34

166

1523

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

170

0.88

0.13

1.3

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.17

0.13

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

105

1.14

0.11

1.3

1.5

0.52

0.53

e9/l

0.01

105

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2155

21593

0.98

0.10

27.5

17.2

42.75

40.52

0.56

2141

21286

(3026361) Erythrocytes [#/volume] in Blood

2155

21592

0.98

0.10

27.1

17.0

4.51

4.50

e12/l

0.43

2128

20975

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

339

1.06

0.10

1.3

1.4

0.29

0.37

nmol/l

0.55

265

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.11

0.09

1.0

1.3

95.40

76.09

ug/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

164

1.10

0.09

2.5

2.1

0.84

1.17

g/24h

0.37

(3010813) Leukocytes [#/volume] in Blood

2156

21600

0.98

0.09

27.1

17.0

7.18

6.51

e9/l

24.85

2129

20978

(3035941) MCH [Entitic mass]

2155

21590

0.98

0.09

27.0

16.9

30.17

30.27

1.85

2142

21293

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

411

4161

0.98

0.09

4.4

4.7

22.01

22.45

0.22

180

2108

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2155

21589

0.98

0.09

27.0

16.9

90.92

90.76

0.86

2142

21290

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1921

19146

1.01

0.09

4.8

4.7

4.60

4.69

mmol/l

3.15

1843

17942

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

725

1.04

0.08

1.3

1.5

62.80

59.51

ug/l

0.26

616

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.78

0.08

9.0

4.2

7.13

9.09

mg/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.04

0.08

1.6

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1907

19013

1.01

0.08

4.7

4.6

1.48

1.50

mmol/l

1.13

1828

17715

(3007461) Platelets [#/volume] in Blood

2155

21582

0.99

0.07

27.1

17.0

264.39

251.27

e9/l

15.67

2129

21032

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

109

1065

1.02

0.07

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

157

1.08

0.07

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

102

0.88

0.06

2.4

1.3

111.67

98.00

ng/l

—

102

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

518

5141

1.01

0.05

5.2

5.8

2.92

4.23

ug/l

0.78

474

4649

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

752

1.02

0.05

1.6

1.4

3.64

3.25

mg/l

0.19

516

(3039443) Prostate specific Ag panel - Serum or Plasma

262

0.95

0.05

1.6

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

433

4300

1.01

0.04

4.3

3.2

91.92

91.49

0.13

423

4199

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

219

1.05

0.04

1.5

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

864

1.02

0.04

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1944

19413

1.00

0.02

5.3

2.67

2.75

mmol/l

3.91

1858

18113

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

701

0.98

0.02

1.3

162.65

216.18

miu/ml

1.03

324

(3026470) Cobalt [Mass/volume] in Blood

106

0.94

0.01

1.6

2.2

1.55

3.06

ug/l

—

101

(4024509) Urine culture

873

1.01

0.00

2.0

1.7

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

596

0.99

0.00

2.0

1.9

—

(3008295) Osmolality of Serum or Plasma

169

1.01

0.00

1.5

1.4

279.18

278.93

mosm/kgh2o

0.01

131

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

299

1.00

0.00

3.1

3.0

32.08

27.93

u/ml

0.13

289

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

116

1.03

0.00

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

104

0.96

0.00

1.3

1.4

36.08

26.29

umol/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.91

0.00

4.0

2.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.91

0.00

1.6

1.7

41.28

41.44

g/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.90

0.00

1.6

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.94

-0.00

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.9

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

1.44

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

7.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

318.37

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.12

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.95

-0.00

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

30.06

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.99

-0.00

3.3

3.0

53.23

51.60

umol/l

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.6

—

3.33

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

313.60

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint ASTHMA_MIXED_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
ASTHMA_MIXED_EXMORE	1.854 [1.7, 2.02]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.331

During the follow-up period (1.1.1998 — 31.12.2019), 2432 out of 11328 females with ASTHMA_MIXED_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
ASTHMA_MIXED_EXMORE	1.806 [1.64, 1.98]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 2457 out of 11523 males with ASTHMA_MIXED_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have ASTHMA_MIXED_EXMORE.

N-year risk	Females	Males
1	0.163%	0.312%
5	1.025%	1.98%
10	2.663%	4.947%
15	5.052%	9.244%
20	9.006%	15.523%

Relationships between endpoints

↥

Index endpoint: ASTHMA_MIXED_EXMORE – Asthma mixed form (mode), excluding more controls

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Asthma mixed form (mode), excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints